<SEC-DOCUMENT>0001104659-25-052998.txt : 20250527
<SEC-HEADER>0001104659-25-052998.hdr.sgml : 20250527
<ACCEPTANCE-DATETIME>20250527162039
ACCESSION NUMBER:		0001104659-25-052998
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250522
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250527
DATE AS OF CHANGE:		20250527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ClearSign Technologies Corp
		CENTRAL INDEX KEY:			0001434524
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35521
		FILM NUMBER:		25988754

	BUSINESS ADDRESS:	
		STREET 1:		8023 E. 63RD PLACE, SUITE 101
		CITY:			TULSA
		STATE:			OK
		ZIP:			74133
		BUSINESS PHONE:		(918) 236-6461

	MAIL ADDRESS:	
		STREET 1:		8023 E. 63RD PLACE, SUITE 101
		CITY:			TULSA
		STATE:			OK
		ZIP:			74133

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLEARSIGN COMBUSTION CORP
		DATE OF NAME CHANGE:	20080507
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2516138d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:clir="http://clearsign.com/20250522">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_clir_clearsign.com_20250522 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20250522_20250522 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001434524 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000004" name="dei:EntityCentralIndexKey">0001434524</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="clir-20250522.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001434524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-22</xbrli:startDate>
        <xbrli:endDate>2025-05-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b>&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_902_edei--DocumentType_c20250522__20250522_zsqU29KHdXXk"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of report (Date of earliest event reported):
<span id="xdx_90C_edei--DocumentPeriodEndDate_c20250522__20250522_z3a4Dh8VXloe"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 22, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityRegistrantName_c20250522__20250522_zvLQ30onn0Dc"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000011" name="dei:EntityRegistrantName">CLEARSIGN TECHNOLOGIES CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20250522__20250522_z7N3lc7I2p64"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityFileNumber_c20250522__20250522_zT3xT30Zq9oe"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000013" name="dei:EntityFileNumber">001-35521</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20250522__20250522_zG205YE6KW62" style="font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000014" name="dei:EntityTaxIdentificationNumber">26-2056298</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction of
    <br/>
incorporation)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font-weight: bold; vertical-align: top; text-align: center"><b>(Commission File Number)</b></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(IRS Employer
    <br/>
Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20250522__20250522_zSxs1zrrkvQf"><b><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000015" name="dei:EntityAddressAddressLine1">8023 E. 63rd Place, Suite 101</ix:nonNumeric></b></span>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityAddressCityOrTown_c20250522__20250522_za6EAHE8pn4b"><b><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000016" name="dei:EntityAddressCityOrTown">Tulsa</ix:nonNumeric></b></span><b>,
<span id="xdx_90C_edei--EntityAddressStateOrProvince_c20250522__20250522_zrrBhn5jwDu1"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">Oklahoma</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20250522__20250522_zYWoJibQkHj2"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000018" name="dei:EntityAddressPostalZipCode">74133</ix:nonNumeric></span></b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Zip Code) </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90A_edei--CityAreaCode_c20250522__20250522_zAfcdLDMgUS3"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000019" name="dei:CityAreaCode">918</ix:nonNumeric></span>) <span id="xdx_900_edei--LocalPhoneNumber_c20250522__20250522_z3RQil0SaQY9"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000020" name="dei:LocalPhoneNumber">236-6461</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant's telephone number, including area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_901_edei--WrittenCommunications_c20250522__20250522_zfAycXFEGmMd"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20250522__20250522_zNesm6RSBDC7"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_905_edei--PreCommencementTenderOffer_c20250522__20250522_zgc3Hei9NlG5"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20250522__20250522_zMSirNXDLIx8"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13(e)-4(c))</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 34%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which <br/>
registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--Security12bTitle_c20250522__20250522_zJliZ8pm87ha"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000025" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--TradingSymbol_c20250522__20250522_z3qmsNrYCHp9"><ix:nonNumeric contextRef="AsOf2025-05-22" id="Fact000026" name="dei:TradingSymbol">CLIR</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--SecurityExchangeName_c20250522__20250522_zMPXsWTRc2Cj"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top"><td style="width: 100%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth
    company </span><span style="font: 10pt Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20250522__20250522_zO3wQkfMUUxk"><ix:nonNumeric contextRef="AsOf2025-05-22" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01. Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;22, 2025 (the
&#8220;Effective Date&#8221;), ClearSign Technologies Corporation (the &#8220;Company&#8221;) entered into a cooperation agreement (the
&#8220;Clarkson Cooperation Agreement&#8221;) with Richard D. Clarkson (collectively with his affiliates and associates, the &#8220;Clarkson
Parties&#8221;) and a cooperation agreement (the &#8220;DiGiandomenico Cooperation Agreement&#8221; and, together with the Clarkson Cooperation
Agreement, the &#8220;Cooperation Agreements&#8221;) with Anthony DiGiandomenico (collectively with his affiliates and associates, the
&#8220;DiGiandomenico Parties&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Cooperation
Agreements, the Clarkson Parties, in connection with the Clarkson Cooperation Agreement, and the DiGiandomenico Parties, in connection
with the DiGiandomenico Cooperation Agreement, each, among other things, (a)&#160;acknowledged the irrevocable withdrawal of letters they
previously delivered to the Company purporting to notify the Company of intent to nominate a director for election to the Company&#8217;s
board of directors (the &#8220;Board&#8221;) at the Company&#8217;s 2025 annual meeting of stockholders (the &#8220;2025 Annual Meeting&#8221;),
and (b)&#160;agreed to irrevocably withdraw all outstanding materials and purported notices submitted to the Company, and cease all solicitation
efforts and other activities, in connection with or related thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Cooperation
Agreements, the Company has agreed to take all necessary actions to increase the size of the Board from five to seven directors, appoint
Louis J. Basenese and Anthony DiGiandomenico (each, a &#8220;New Director&#8221; and together, the &#8220;New Directors&#8221;) to the
Board, and nominate each New Director as a candidate for election to the Board at the 2025 Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From the Effective Date until
the earlier of (x)&#160;the date immediately following the conclusion of the Company&#8217;s 2026 annual meeting of stockholders and (y)&#160;the
occurrence of a Change of Control transaction (as defined in the Cooperation Agreements) (together, such term lengths of the Cooperation
Agreements, the &#8220;Term&#8221;), the Clarkson Parties and the DiGiandomenico Parties have agreed to vote all Voting Securities (as
defined in the Cooperation Agreements) beneficially owned by them at all meetings of the Company&#8217;s stockholders, or to execute a
consent with respect to such Voting Securities, in accordance with the Board&#8217;s recommendations on all proposals submitted to stockholders,
except that the Clarkson Parties and the DiGiandomenico Parties may vote in their discretion on any proposal of the Company in respect
of any Extraordinary Transaction (as defined in the Cooperation Agreements). The Clarkson Parties and the DiGiandomenico Parties have
also agreed to certain customary standstill provisions during the Term, prohibiting them from, among other things, (i)&#160;soliciting
proxies, (ii)&#160;communicating with stockholders of the Company pursuant to Rule&#160;14a-1(l)(2)(iv)&#160;under the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;), (iii)&#160;taking public actions to change or influence the Board, management
or the direction of certain Company matters, and (iv)&#160;acquiring an aggregate beneficial ownership of more than 3.5% of the outstanding
shares of the Company&#8217;s common stock or Voting Securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the Term, the Company
and the Clarkson Parties and the DiGiandomenico Parties, as applicable, have agreed that they will not disparage each other and that they
will not threaten, initiate, encourage or pursue, alone or in concert with others, or knowingly assist any other person to threaten, initiate,
encourage or pursue, any lawsuit, claim, or proceeding with respect to any claims against the Company or a Clarkson Party or DiGiandomenico
Party, as applicable, except for any legal proceeding initiated solely to remedy a breach of or to enforce the Cooperation Agreements.
The Clarkson Parties and the DiGiandomenico Parties have also granted the Company a general release from any claims arising on or prior
to the date of the applicable Cooperation Agreement, subject to limited exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has agreed to
pay, immediately following full payment of all fees and expenses incurred by the Special Committee to its advisors, an amount not to exceed
in the aggregate $2,000 to Mr.&#160;Clarkson and an amount not to exceed in the aggregate $20,000 to Mr.&#160;DiGiandomenico in exchange
for the general release and as reimbursement for reasonable, well-documented out-of-pocket fees and expenses incurred by Mr.&#160;Clarkson
or Mr.&#160;DiGiandomenico, as applicable, in connection with the negotiation, execution and effectuation of the applicable Cooperation
Agreement and the transactions contemplated by such Cooperation Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing descriptions
of the Clarkson Cooperation Agreement and the DiGiandomenico Cooperation Agreement contained in this Current Report on Form&#160;8-K do
not purport to be complete and are qualified in their entirety by reference to the full terms and conditions of the Clarkson Cooperation
Agreement and the DiGiandomenico Cooperation Agreement, which are filed with this Current Report on Form&#160;8-K as Exhibit&#160;10.1
and 10.2, respectively, and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item&#8201;5.02. Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Appointment of Directors and Increase to Board&#8217;s
Size</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Effective Date, the
Board increased the size of the Board from five to seven directors and appointed each New Director as a member of the Board, effective
immediately, for initial terms expiring at the 2025 Annual Meeting. Each New Director will receive the same compensation for his service
as a director as the compensation received by other non-management directors on the Board, which compensation arrangements are described
under the heading &#8220;Director Compensation Plan&#8221; in the Company&#8217;s annual report on Form&#160;10-K filed with the Securities
and Exchange Commission (the &#8220;SEC&#8221;) on March&#160;31, 2025, as adjusted by the Board from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently with the appointment
of the New Directors to the Board, the Board determined that Mr.&#160;Basenese qualifies as independent under the listing rules&#160;of
the Nasdaq Stock Market LLC and appointed Mr.&#160;Basenese to the Human Capital and Compensation Committee (the &#8220;Compensation Committee&#8221;).
Mr.&#160;DiGiandomenico was determined by the Board, in reliance on the determination of the Special Committee of the Board, to not be
independent and has not been appointed to any committees of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except for the Cooperation
Agreements described in Item 1.01 above, there are no arrangements or understandings between either New Directors and any other person
pursuant to which either New Director was selected as a director, or transactions in which either New Director has an interest requiring
disclosure under Item 404(a)&#160;of Regulation S-K. There are no family relationships between either New Director and any of the Company&#8217;s
officers and directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;Basenese, age 47,
brings over 25 years of experience with equity research and analysis, investment banking, strategic planning, thought leadership development
and investor relations. Mr.&#160;Basenese has served as Executive Vice President &#8211; Market Strategy for Prairie Operating Co. (Nasdaq:
PROP), a Houston-based publicly traded independent energy company engaged in the development and acquisition of oil and natural gas resources
in the United States, since January&#160;2025. He has also served as CEO and Chief Strategist of The Basenese Group, LLC, a full service
equity research, strategy and advisory firm, since February&#160;2005. Mr.&#160;Basenese has also served on the board of directors of
ENDRA Life Sciences,&#160;Inc. (Nasdaq: NDRA), a life sciences company that develops technologies to improve the capabilities of clinical
diagnostic ultrasound, since March&#160;2020, and the board of directors of The Roberto Clemente Health Clinic, a U.S.-based non-profit
that provides affordable access to high quality health care and wellness programs in the Tola coastal communities of Nicaragua to more
than 12,000 patients per year, since April&#160;2021. Prior to his current roles, Mr.&#160;Basenese served as President and Chief Market
Strategist of MDB Capital Holdings, LLC (Nasdaq: MDBH), a broker-dealer and financial advisory firm based in Dallas, Texas, since October&#160;2022.
Prior to that role, he was the co-founder and served as Chief Analyst for Disruptive Tech Research, an independent equity research and
advisory firm, from June&#160;2014 to June&#160;2023. Prior to that, he served in various analyst, strategist and account executive roles
at Wall Street Daily, an affiliate of Agora,&#160;Inc., The Oxford Club, another affiliate of Agora,&#160;Inc., Morgan Stanley,&#160;Inc.
and Commonwealth Risk. Mr.&#160;Basenese holds an MBA from the Crummer Graduate School of Business at Rollins College and a BA in English
from the University of Florida.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;DiGiandomenico, age
58, has been the Chief of Transactions and director of MDB Capital Holdings, LLC since inception on August&#160;10, 2021. Mr.&#160;DiGiandomenico
has also served on the board of directors of ENDRA Life Sciences Inc. (Nasdaq: NDRA), a developer of enhanced ultrasound technology, from
July&#160;2013 until present, the board of directors of Provention Bio,&#160;Inc., a developer of multiple drug therapies, from January&#160;2017
until May&#160;2020 and the board of directors of Cue Biopharma,&#160;Inc., a company that develops novel biologic drugs for the selective
modulation of the human immune system to treat a broad range of cancers and autoimmune disorders from January&#160;2016 to October&#160;2019.
Since he co-founded MDB Capital Holdings, LLC (formerly known as MDB Capital Group, LLC) in 1997, Mr.&#160;DiGiandomenico has been enabling
investment into early-stage disruptive technologies. He has worked alongside a wide range of companies in biotechnology, medical devices,
high technology, and renewable energy spaces. Mr.&#160;DiGiandomenico holds an MBA from the Haas School of Business at the University
of California, Berkeley and a BS in Finance from the University of Colorado.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with their appointment,
each New Director received an offer letter from the Company, effective as of the Effective Date (each an &#8220;Offer Letter&#8221; and
together, the &#8220;Offer Letters&#8221;), setting forth the terms of their services as directors and their compensation arrangement,
which each New Director accepted. Pursuant to the Offer Letters and in accordance with the Company&#8217;s director compensation policies,
each New Director will be eligible to receive restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2021 Equity Incentive
Plan on the first day of every quarter that such New Director serves on the Board (each, a &#8220;Grant Date&#8221;) in an amount of $15,000
for serving as a member of the Board and, with respect to Mr.&#160;Basenese, $750 for serving as a member of the Compensation Committee,
payable on each Grant Date during each New Director&#8217;s term of service, with the value of the applicable RSUs determined at the applicable
Grant Date. The initial grant amount of RSUs that each New Director will be eligible to receive upon each of their appointments will be
pro-rated for the portion of the quarter ending June&#160;30, 2025 during which each New Director serves on the Board. Mr.&#160;DiGiandomenico
declined to accept the initial pro-rated grant of RSUs for the quarter ending June&#160;30, 2025, that he was eligible to receive upon
his appointment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Offer Letters do not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified
in its entirety by reference to the Offer Letters, which are included as Exhibit&#160;10.3 and Exhibit&#160;10.4 to this Current Report
on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with their appointments,
each New Director will enter into the Company&#8217;s standard form of indemnification agreement, the form of which was filed as <a href="https://www.sec.gov/Archives/edgar/data/1434524/000155837023014714/clir-20230630xex10d1.htm" style="-sec-extract: exhibit">Exhibit&#160;10.1</a>
to the Company&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on August&#160;14, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
in Item 1.01 of this Current Report on Form&#160;8-K is incorporated into this Item 5.02 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Refusal of Director to Stand for Re-Election</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 27, 2025, David M. Maley notified the Company that he will not
stand for re-election as a director of the Company upon the expiration of his current term, which expires at the 2025 Annual Meeting.
Mr. Maley currently serves as a member of the Board and the Board&#8217;s Audit and Risk Committee, Nominating and Corporate Governance
Committee and Compensation Committee. Mr. Maley&#8217;s refusal to stand for re-election was not the result of any disagreement with the
Company, known to an executive officer of the Company, on any matter relating to the Company&#8217;s operations, policies or practices.
The Board has not yet determined whether it will reduce its size or nominate a replacement director at this time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01 Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
May 27, 2025, the Company issued a press release announcing the actions described above. A copy of the press release is being furnished
as Exhibit 99.1 to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
information in this Item 7.01, including Exhibit 99.1, is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference into any of the Company&#8217;s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before
or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth
by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. </b></span><b>Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>(d)&#160;Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2516138d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2516138d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cooperation Agreement, dated May&#160;22, 2025, by and between ClearSign Technologies Corporation and Richard D. Clarkson.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2516138d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2516138d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cooperation Agreement, dated May&#160;22, 2025, by and between ClearSign Technologies Corporation and Anthony DiGiandomenico.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2516138d1_ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2516138d1_ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louis J. Basenese&#8217;s Offer Letter, effective as of May&#160;22, 2025.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2516138d1_ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2516138d1_ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony DiGiandomenico&#8217;s Offer Letter, effective as of May&#160;22, 2025.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="https://www.sec.gov/Archives/edgar/data/1434524/000155837023014714/clir-20230630xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5**</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1434524/000155837023014714/clir-20230630xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Indemnification Agreement (incorporated by reference to Exhibit&#160;10.1 of the Quarterly Report on Form&#160;10-Q filed with the SEC on August&#160;14, 2023).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2516138d1_ex99-1.htm">99.1***</a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2516138d1_ex99-1.htm">Press Release, dated May 27, 2025.</a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">* Filed herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">** Previously filed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*** Furnished herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf
by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dated: May&#160;27, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CLEARSIGN TECHNOLOGIES CORPORATION</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Colin James Deller</span></td>
    <td style="width: 50%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colin James Deller</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fo1RQfpoqCJWkSLia7BbCbbZsol/R/KWxhZxWViWmW9GiIFY0dLWyHBaFDkcsGlrExAKrJDRnTE69HqTQrwFXqwPbFzo3h+oKTIYmdlQTUwUOuvdeixTkPORVCM1BTlNpYT9ViRfXZOrbIkuWFODcSXsmVq2GAy/+oSDeZKj5tVVHZG9JZfCeCh7+Q1KjhXs6G4exFcPea5FMugmESumWxtd2TOg+5KQ1djEOt/T/00+A3pKhw== -->
</body> </html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2516138d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COOPERATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Cooperation Agreement
(this &ldquo;<B>Agreement</B>&rdquo;), effective as of May&nbsp;22, 2025 (the&nbsp;&ldquo;<B>Effective Date</B>&rdquo;), is entered into
by and between ClearSign Technologies Corporation, a Delaware corporation (&ldquo;<B>ClearSign</B>&rdquo;), and Richard D. Clarkson (collectively
with his Affiliates and Associates, the &ldquo;<B>Investor Parties</B>,&rdquo; and each, an &ldquo;<B>Investor Party</B>&rdquo;). ClearSign
and the Investor Parties are together referred to herein as the &ldquo;<B>Parties</B>,&rdquo; and each, a &ldquo;<B>Party</B>.&rdquo;
Unless otherwise defined herein, capitalized terms shall have the meanings given to them in <U>Section&nbsp;16</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
on January&nbsp;15, 2025 and February&nbsp;25, 2025, the Investor Parties delivered letters to ClearSign pursuant to Article&nbsp;III,
Section&nbsp;3.2 of the Bylaws purporting to notify ClearSign of intent to nominate a director for election to the board of directors
of ClearSign (the &ldquo;<B>Board</B>&rdquo;) at ClearSign&rsquo;s 2025 annual meeting of stockholders (including, without limitation,
any adjournments or postponements thereof and any meeting which may be called in lieu thereof) (the &ldquo;<B>2025 Annual Meeting</B>&rdquo;)
(such letters, together, the &ldquo;<B>Clarkson Purported Notice</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
on March&nbsp;25, 2025, the Investor Parties notified ClearSign of the withdrawal of the Clarkson Purported Notice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
the Investor Parties beneficially own an aggregate of 138,000 shares of ClearSign&rsquo;s common stock, par value $0.0001 per share (the
 &ldquo;<B>Common Stock</B>&rdquo;), as of the Effective Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B></FONT>,
ClearSign has reached an agreement with the Investor Parties with respect to certain matters, as provided for in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B></FONT>, in consideration of the premises, representations and mutual covenants and agreements set forth herein, and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Withdrawal
of the Investor Parties&rsquo; Campaigns and Related Matters</U>. Concurrently with and effective upon the execution of this Agreement,
the Investor Parties (a)&nbsp;hereby acknowledge that the Clarkson Purported Notice was irrevocably withdrawn on March&nbsp;25, 2025 and
(b)&nbsp;shall irrevocably withdraw or cause the irrevocable withdrawal of any and all outstanding and yet to be withdrawn materials and
notices submitted to ClearSign in connection with or related to the Clarkson Purported Notice, and shall take all necessary action to
immediately cease any and all solicitation efforts and other activities in connection with the Clarkson Purported Notice and any and all
related materials and notices (other than in connection with such withdrawal).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Board
Composition and Other Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>New
Directors</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
soon as reasonably practicable following the Effective Date, the Board, and all applicable committees of the Board, shall take all necessary
actions to: (A)&nbsp;increase the size of the Board from five (5)&nbsp;to seven (7)&nbsp;directors, and (B)&nbsp;appoint (x)&nbsp;Louis&nbsp;J.
Basenese (the &ldquo;<B>First New Director</B>&rdquo;) to serve as a director, who shall fill one (1)&nbsp;of the newly created vacancies
resulting from the increase in the size of the Board, and (y)&nbsp;Anthony DiGiandomenico (the &ldquo;<B>Second New Director</B>&rdquo;
and, together with the First New Director, the &ldquo;<B>New Directors</B>&rdquo;) to serve as a director, who shall fill the other newly
created vacancy resulting from the increase in the size of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Board, and all applicable committees of the Board, shall take all necessary actions to nominate each New Director as a candidate for election
to the Board at the 2025 Annual Meeting. ClearSign shall recommend, support and solicit proxies for the election of each New Director
at the 2025 Annual Meeting in the same manner as ClearSign has supported its nominees for election at prior annual meetings of stockholders
at which the election of directors was uncontested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Prior
to the appointment of the New Directors, (A)&nbsp;the Board has determined that the First New Director is an &ldquo;Independent Director,&rdquo;
as defined in the listing rules&nbsp;of the Nasdaq Stock Market LLC (&ldquo;<B>Nasdaq</B>&rdquo;) and (B)&nbsp;the Special Committee of
the Board has determined that the Second New Director is not an &ldquo;Independent Director,&rdquo; as defined in the listing rules&nbsp;of
Nasdaq. In connection with the foregoing, and as a condition to ClearSign&rsquo;s obligation to appoint each New Director to the Board,
each New Director has (x)&nbsp;provided (1)&nbsp;such information required to be or is customarily disclosed by directors or director
candidates in proxy statements or other filings under applicable law or stock exchange regulations, (2)&nbsp;such information reasonably
requested by the Board in connection with assessing eligibility, independence and other criteria applicable to directors or satisfying
compliance and legal obligations and (3)&nbsp;a fully completed and executed copy of ClearSign&rsquo;s director candidate questionnaire
(substantially in the form completed by ClearSign&rsquo;s incumbent non-management directors), in each case, as promptly as practicable
to, among other reasons, enable the timely filing of ClearSign&rsquo;s proxy statement and other periodic reports with the U.S. Securities
and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), and (y)&nbsp;participated in (1)&nbsp;customary procedures for new director candidates,
including, without limitation, an appropriate background check, comparable to those undergone by other non-management directors of ClearSign
and (2)&nbsp;an interview with the Nominating and Corporate Governance Committee of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Committees</U>.
Following the appointment of the New Directors to the Board, the Board, and all applicable committees of the Board, shall take all necessary
actions to appoint the New Directors to the Human Capital and Compensation Committee of the Board (the &ldquo;<B>Compensation Committee</B>&rdquo;),
subject to each New Director meeting the applicable eligibility requirements for committee membership, including, without limitation,
a determination by the Board, in its sole and unencumbered discretion, that such New Director is an &ldquo;Independent Director&rdquo;
as defined in the listing rules&nbsp;of Nasdaq; <U>provided</U>, <U>however</U>, that the Board shall not be required to appoint a New
Director to the Compensation Committee if the Board determines, or has determined, such New Director not to be an &ldquo;Independent Director&rdquo;
as defined in the listing rules&nbsp;of Nasdaq; <U>provided</U>, <U>further</U>, that the Board is entitled to, and shall, rely on the
finding and conclusion of the Special Committee of the Board which determines that the Second New Director is not an &ldquo;Independent
Director&rdquo; as such term is defined in the listing rules&nbsp;of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Board
Policies and Procedures</U>. Each Party acknowledges that each New Director, upon his appointment to the Board and for so long as he
is a member of the Board, shall be governed by all of the same policies, processes, procedures, codes, rules, standards and guidelines
applicable to members of the Board, including, without limitation, ClearSign&rsquo;s Code of Business Conduct and Ethics, Clawback Policy,
Policy Regarding Stockholder Candidates for Nomination and any other policies on stock ownership, insider trading, anti-hedging, corporate
governance, public disclosures and confidentiality (collectively, the&nbsp;&ldquo;<B>Company Policies</B>&rdquo;) and all applicable
rules&nbsp;and regulations of Nasdaq, and will be required to strictly adhere to ClearSign&rsquo;s policies on confidentiality imposed
on all members of the Board. ClearSign agrees that, upon his appointment to the Board and for so long as he is a member of the Board,
each New Director shall receive (i)&nbsp;the same benefits of director and officer insurance and any indemnity and exculpation arrangements
as all other non-management directors on the Board, (ii)&nbsp;the same compensation for his service as a director as the compensation
received by other non-management directors on the Board and (iii)&nbsp;such other benefits on the same basis as all other non-management
directors on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Voting</U>.
From the Effective Date until the Termination Date (as defined below) (the &ldquo;<B>Standstill Period</B>&rdquo;), each Investor Party
agrees that it will appear in person or by proxy at each annual or special meeting of stockholders of ClearSign (including, without limitation,
any adjournments, postponements, reschedulings or continuations thereof and any meeting which may be called in lieu thereof), whether
such meeting is held at a physical location or virtually by means of remote communications or a hybrid combination thereof, and will vote
(or execute a consent with respect to) all Voting Securities beneficially owned by such Investor Party as of the applicable record date
in accordance with the Board&rsquo;s recommendations with respect to (a)&nbsp;the election, removal or replacement of any director, (b)&nbsp;the
ratification of the appointment of ClearSign&rsquo;s independent registered public accounting firm, (c)&nbsp;ClearSign&rsquo;s &ldquo;say-on-pay&rdquo;
proposal and (d)&nbsp;any other proposal to be submitted to the stockholders of ClearSign by either ClearSign or any stockholder of ClearSign;
<U>provided</U>, <U>however</U>, that the Investor Parties shall be permitted to vote in their sole discretion on any proposal of ClearSign
in respect of any Extraordinary Transaction. During the Standstill Period, each Investor Party agrees that it will not engage in any course
of conduct with the purpose of causing stockholders of ClearSign to vote contrary to the recommendation of the Board on any of the aforementioned
matters enumerated in subclauses&nbsp;(a)&ndash;(d)&nbsp;presented to ClearSign&rsquo;s stockholders for their vote at any meeting of
ClearSign&rsquo;s stockholders or by written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Mutual
Non-Disparagement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to <U>Section&nbsp;6</U> hereof, each Investor Party agrees that, during the Standstill Period, neither it nor any of its Representatives
shall, and it shall cause each of its Representatives to not, directly or indirectly, in any capacity or manner, make, express, transmit,
speak, write, verbalize or otherwise communicate in any way (or cause, further, assist, solicit, encourage, support or participate in
any of the foregoing), any remark, comment, message, information, declaration, communication or other statement of any kind (including,
without limitation, through the use of any social or professional networking websites and/or blogs), whether verbal, in writing, electronically
transferred or otherwise, that might reasonably be construed to be derogatory or critical of, or negative toward, or constitute an <I>ad
hominem</I> attack on, or otherwise disparage, defame, damage, criticize, condemn or impugn the reputation or good name of ClearSign or
any of its Representatives, former directors and officers, or any of their respective businesses, products, services, actions, writings,
policies or practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>ClearSign
agrees that, during the Standstill Period, neither it nor any of its Representatives shall, and it shall cause each of its Representatives
to not, directly or indirectly, in any capacity or manner, make, express, transmit, speak, write, verbalize or otherwise communicate in
any way (or cause, further, assist, solicit, encourage, support or participate in any of the foregoing), any remark, comment, message,
information, declaration, communication or other statement of any kind (including, without limitation, through the use of any social or
professional networking websites and/or blogs), whether verbal, in writing, electronically transferred or otherwise, that might reasonably
be construed to be derogatory or critical of, or negative toward, or constitute an <I>ad hominem</I> attack on, or otherwise disparage,
defame, damage, criticize, condemn or impugn the reputation or good name of any Investor Party or any of their respective Representatives,
or any of their respective businesses, products, services, actions, writings, policies or practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
the foregoing, nothing in this <U>Section&nbsp;4</U> or elsewhere in this Agreement shall prohibit any Party from making any factual statement
or disclosure as may be required under the federal securities laws or other applicable laws (including, without limitation, to comply
with the terms of any valid subpoena, order or other legal process from any governmental or regulatory authority with competent jurisdiction
over the relevant Party), or stock exchange regulations; <U>provided</U>,&nbsp;<U>however</U>, that, unless prohibited under applicable
law, such Party must provide written notice to the other Party at least two (2)&nbsp;business days prior to making any such statement
or disclosure required under the federal securities laws or other applicable laws or stock exchange regulations that would otherwise be
prohibited by the provisions of this&nbsp;<U>Section&nbsp;4</U>, and reasonably consider any comments of such other Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
limitations set forth in <U>Sections 4(a)</U>&nbsp;and <U>4(b)</U>&nbsp;hereof shall not prevent any Party from responding to any public
statement made by the other Party of the nature described in <U>Sections 4(a)</U>&nbsp;and <U>4(b)</U>&nbsp;hereof if such statement by
the other Party was made in breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Litigation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Each
Investor Party covenants and agrees solely for and on behalf of itself that, during the Standstill Period, it shall not, and shall not
permit any of its Representatives to (solely in the context of their representation of such Investor Party in connection with the subject
matter of this Agreement), alone or in concert with others, threaten, initiate,&nbsp;encourage or pursue, or knowingly assist any other
person to threaten, initiate, encourage or pursue, any lawsuit, claim or proceeding (including, without limitation, the Investor Parties
commencing, encouraging or supporting any derivative or similar action in the name of ClearSign) before any court or governmental, administrative
or regulatory body (collectively, &ldquo;<B>Legal Proceeding</B>&rdquo;) with respect to any Claims (as defined below) against ClearSign,
except for any Legal Proceeding initiated solely to remedy a breach of or to enforce this Agreement; <U>provided</U>, <U>however</U>,
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>the
foregoing shall not prevent (A)&nbsp;the Investor Parties or any of their respective Representatives (solely in the context of their representation
of such Investor Party in connection with the subject matter of this Agreement), from responding to oral questions, interrogatories, requests
for information or documents, subpoenas, civil investigative demands or similar processes (a &ldquo;<B>Legal Requirement</B>&rdquo;) in
connection with any Legal Proceeding if such Legal Proceeding has not been initiated by, or on behalf of, or with the material assistance
of, the Investor Parties or any of their Representatives (solely in the context of their representation of such Investor Party in connection
with the subject matter of this Agreement) or (B)&nbsp;the exercise of statutory appraisal rights; <U>provided</U>, <U>further</U>, that,
in the event that any of the Investor Parties or any of their Representatives receives such Legal Requirement, such Investor Party shall,
unless prohibited by applicable law, give prompt written notice of such Legal Requirement to ClearSign; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>this
<U>Section&nbsp;5(a)</U>&nbsp;shall not require any Investor Party to opt out of any class action lawsuits against ClearSign commenced
and maintained by persons other than an Investor Party and its Affiliates unless such lawsuit was initiated in violation of this <U>Section&nbsp;5(a)</U>&nbsp;(&ldquo;<B>Class&nbsp;Actions</B>&rdquo;)
or the Investor Party is a party other than as a result of the Investor Parties&rsquo; ownership of Common Stock during the class period
applicable to such Class&nbsp;Actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>ClearSign
covenants and agrees that, during the Standstill Period, it shall not, and shall not permit any of its Representatives to (solely in the
context of their representation of ClearSign in connection with the subject matter of this Agreement), alone or in concert with others,
threaten, initiate,&nbsp;encourage or pursue, or knowingly assist any other person to threaten, initiate, encourage or pursue, any Legal
Proceedings with respect to any Claim against any of the Investor Parties, except for any Legal Proceeding initiated solely to remedy
a breach of or to enforce this Agreement; <U>provided</U>, <U>however</U>, that the foregoing shall not prevent (A)&nbsp;ClearSign or
any of its Representatives (solely in the context of their representation of ClearSign in connection with the subject matter of this Agreement),
from responding to a Legal Requirement in connection with any Legal Proceeding if such Legal Proceeding has not been initiated by, or
on behalf of, ClearSign or any of its Representatives (solely in the context of their representation of ClearSign in connection with the
subject matter of this Agreement) or (B)&nbsp;the exercise of statutory appraisal rights; <U>provided</U>, <U>further</U>, that, in the
event ClearSign or any of its Representatives receives such Legal Requirement, ClearSign shall, unless prohibited by applicable law, give
prompt written notice of such Legal Requirement to the Investor Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
the fullest extent permitted by law, the Investor Parties, on behalf of themselves and for all of their Affiliates, Associates, parent
and subsidiary entities, joint ventures and partnerships, successors, assigns and the respective owners, officers, directors, partners,
members, managers, principals, parents, subsidiaries, predecessor entities, agents, employees, stockholders, advisors, consultants, attorneys,
heirs, executors, administrators, successors and assigns of any such person irrevocably, completely and unconditionally release, settle,
acquit and forever discharge ClearSign and ClearSign&rsquo;s Affiliates, Associates, parent and subsidiary entities, joint ventures and
partnerships, successors, assigns, and their respective owners, officers, directors, partners, members, managers, principals, parents,
subsidiaries, predecessor entities, agents, employees, stockholders, advisors, consultants, attorneys, heirs, executors, administrators,
successors and assigns of any such person, jointly or severally, from any and all causes of action, claims, actions, rights, judgments,
obligations, damages, amounts, demands, leases, controversies, suits, contentions, complaints, promises, accountings, bonds, bills, debts,
liabilities, dues, sums of money, expenses, specialties and fees and costs (whether direct, indirect or consequential, incidental or otherwise
including, without limitation, attorney&rsquo;s fees or court costs, of whatever nature) incurred in connection therewith of any kind
or nature whatsoever, foreseen, unforeseen, known or unknown, in their own right, representatively, derivatively or in any other capacity,
in law or in equity or liabilities of whatever kind or character, arising under federal, state, foreign, or common law or the laws of
any other relevant jurisdiction from the beginning of time to the date of this Agreement (the &ldquo;<B>Claims</B>&rdquo;) (such release
by the Investor Parties, the &ldquo;<B>Release</B>&rdquo;);&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that this release and waiver of
the Claims shall not include claims to enforce the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Investor Parties hereby acknowledge that, as of the Effective Date, the Investor Parties may have claims against ClearSign that an Investor
Party does not know or suspect to exist in its favor, including, without limitation, claims that, had they been known, might have affected
the decision to enter into this Agreement, or to provide the Release. In connection with any such claims, other than any claims to enforce
the terms of this Agreement, the Investor Parties agree that they intend to waive, relinquish and release any and all provisions, rights
and benefits any state or territory of the United States or other jurisdiction that purports to limit the application of a release to
unknown claims, or to facts unknown at the time the release was entered into, subject to the foregoing exclusions. In connection with
this waiver, the Investor Parties acknowledge that they, or any of them, may (including, without limitation, after the Effective Date)
discover facts in addition to or different from those known or believed by them to be true with respect to the subject matter of the Release,
but it is the intention of the Investor Parties to completely, fully, finally and forever compromise, settle, release, discharge and extinguish
any and all claims, other than excluded herein, that they may have against ClearSign, known or unknown, suspected or unsuspected, contingent
or absolute, accrued or unaccrued, apparent or unapparent, that now exist or previously existed, without regard to the subsequent discovery
of additional or different facts. The Investor Parties acknowledge that the foregoing waiver is a key, bargained for element to this Agreement
and the Release that is part of it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Standstill</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>During
the Standstill Period, unless otherwise approved by the Board or by ClearSign, each Investor Party shall not, and shall cause its Representatives
not to, directly or indirectly:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>acquire,
offer or seek to acquire, agree to acquire or acquire rights or options to acquire, whether by purchase, tender or exchange offer, through
the acquisition of control of another person, by joining a group, through swap or hedging transactions or otherwise, (A)&nbsp;any securities
of ClearSign, any rights decoupled from the underlying securities of ClearSign, or any derivative securities, contracts or instruments
in any way related to the price of shares of Common Stock, in each case, if such acquisition, offer or seeking to acquire, agreement or
transaction would result in any Investor Party having beneficial ownership of more than 3.5% of the Common Stock or Voting Securities
outstanding at such time, including, without limitation, through the exercise of, or acquisition of, derivative securities or (B)&nbsp;any
assets or liabilities of ClearSign;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>make
any public announcement or proposal with respect to, or offer, seek, propose or indicate an interest in, (A)&nbsp;any form of business
combination or acquisition or other transaction relating to a material amount of assets or securities of ClearSign or any of its subsidiaries,
(B)&nbsp;any form of restructuring, recapitalization or similar transaction with respect to ClearSign or any of its subsidiaries or (C)&nbsp;any
form of tender or exchange offer for Voting Securities, whether or not such transaction involves a Change of Control;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>in
respect of those matters enumerated in <U>Section&nbsp;3</U> hereof, other than as may be required by reason of employment in a broker-dealer
in the ordinary course, engage in, or assist in the engagement in (including, without limitation, engagement by use of or in coordination
with a universal proxy card), any solicitation of proxies or written consents to vote any Voting Securities, communicate with stockholders
of ClearSign pursuant to Rule&nbsp;14a-1(l)(2)(iv)&nbsp;under the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and
regulations promulgated thereunder (the &ldquo;<B>Exchange Act</B>&rdquo;), or conduct, or assist in the conducting of, any type of binding
or nonbinding referendum with respect to any Voting Securities, or assist or participate in any other way, directly or indirectly, in
any solicitation of proxies (or written consents) with respect to, or from the holders of, any Voting Securities, or otherwise become
a &ldquo;participant&rdquo; in a &ldquo;solicitation,&rdquo; as such terms are defined in Instruction 3 of Item 4 of Schedule&nbsp;14A
and Rule&nbsp;14a-1 of Regulation 14A, respectively, under the Exchange Act, to vote any securities of ClearSign (including, without limitation,
by initiating, encouraging or participating in any &ldquo;withhold&rdquo; or similar campaign);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>sell,
offer or agree to sell directly or indirectly, through swap or hedging transactions or otherwise, any Voting Securities or any rights
decoupled from the underlying securities held by any Investor Party to any person who is not (A)&nbsp;a Party to this Agreement, (B)&nbsp;a
member of the Board, (C)&nbsp;an officer of ClearSign or (D)&nbsp;an Affiliate or Associate of any Party (any person not set forth in
clauses (A)&nbsp;through (D)&nbsp;shall be referred to as a &ldquo;<B>Third Party</B>&rdquo;) with a known history of activism or known
plans to engage in activism or that would knowingly (after due inquiry) result in such Third Party, collectively with its Affiliates,
owning, controlling or otherwise having any beneficial or other ownership interest representing in the aggregate in excess of 4.9% of
the shares of Common Stock outstanding at such time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>take
any public action in support of or make any public proposal or request that constitutes or would result in: (A)&nbsp;advising, controlling,
changing, replacing or influencing any director or member of management of ClearSign, including, without limitation, any plans or proposals,
and/or consenting to the calling of any special meeting of stockholders to effect such plans or proposals, to change the number or term
of directors or to fill any vacancies on the Board, except as set forth in this Agreement, (B)&nbsp;any material change in the capitalization,
stock repurchase programs and practices or dividend policy of ClearSign, (C)&nbsp;any other material change in ClearSign&rsquo;s management,
business or corporate structure, (D)&nbsp;seeking to have ClearSign waive or make amendments or modifications to the Certificate of Incorporation,
the Bylaws or the Policy Regarding Stockholder Candidates for Nomination (collectively, the &ldquo;<B>Governing Materials</B>&rdquo;)
or any other actions that may impede or facilitate the acquisition of control of ClearSign by any person, (E)&nbsp;causing a class of
securities of ClearSign to be delisted from, or to cease to be authorized to be quoted on, any securities exchange or (F)&nbsp;causing
a class of securities of ClearSign to become eligible for termination of registration pursuant to Section&nbsp;12(g)(4)&nbsp;of the Exchange
Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>act
by making public announcements or speaking to reporters or members of the media (whether &ldquo;on the record&rdquo; or on &ldquo;background&rdquo;
or &ldquo;off the record&rdquo;), to seek to influence ClearSign&rsquo;s stockholders, management or the Board with respect to ClearSign&rsquo;s
policies, operations, balance sheet, capital allocation, marketing approach, business configuration, Extraordinary Transactions or strategy
or to obtain representation of the Board or seek the removal of any director in any manner, except as expressly permitted by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>call
or seek to call, or request the call of, alone or in concert with others, any meeting of stockholders, whether or not such a meeting is
permitted by the Governing Materials, including, without limitation, a &ldquo;town hall meeting&rdquo;;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>deposit
any Voting Securities in any voting trust or subject any Voting Securities to any arrangement or agreement with respect to the voting
of any Voting Securities (other than (A)&nbsp;any such voting trust, arrangement or agreement solely between the Investor Parties that
is otherwise in accordance with this Agreement or (B)&nbsp;customary brokerage accounts, margin accounts, prime brokerage accounts and
the like);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>seek,
or knowingly encourage or advise any person, to submit nominations in furtherance of a &ldquo;contested solicitation&rdquo; for the election
or removal of directors with respect to ClearSign or seek, or knowingly encourage or take any other action with respect to the election
or removal of any directors of ClearSign;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>form,
join or in any other way participate in any &ldquo;group&rdquo; (within the meaning of Section&nbsp;13(d)(3)&nbsp;of the Exchange Act)
with respect to any of the Voting Securities; <U>provided</U>, <U>however</U>, that nothing herein shall limit the ability of an Affiliate
of any Investor Party to join in a &ldquo;group&rdquo; with any other Investor Party or Affiliate thereof comprising such Investor Party
following the execution of this Agreement, so long as any such Affiliate agrees in writing to be subject to, and bound by, the terms and
conditions of this Agreement and, if required under the Exchange Act, files a Schedule&nbsp;13D or an amendment thereof, as applicable,
within two (2)&nbsp;business days after disclosing that such Investor Party has formed a group with such Affiliate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>demand
a copy of ClearSign&rsquo;s list of stockholders or its other books and records or make any request pursuant to Rule&nbsp;14a-7 under
the Exchange Act or under any statutory or regulatory provisions of the State of Delaware providing for stockholder access to books and
records (including, without limitation, lists of stockholders) of ClearSign;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(xii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>make
any request or submit any proposal to amend or waive the terms of this <U>Section&nbsp;6</U> other than through non-public communications
with ClearSign that would not be reasonably likely to trigger public disclosure obligations for any Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(xiii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>comment
publicly about or disclose in a manner that could reasonably be expected to become public any intent, purpose, plan or proposal with respect
to any transactions involving ClearSign, any director or member of management, policies, strategy, operations, financial results or affairs,
any of its securities or assets, or this Agreement that is inconsistent with the provisions of this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(xiv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>enter
into any discussions, negotiations, agreements or understandings with any person with respect to any action that the Investor Parties
are prohibited from taking pursuant to this <U>Section&nbsp;6</U>, or advise, assist, encourage or seek to persuade any person to take
any action or make any statement with respect to any such action or otherwise take or cause any action or make any statement inconsistent
with any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
anything to the contrary contained in this <U>Section&nbsp;6</U>, each Investor Party shall not be prohibited or restricted from: (A)&nbsp;communicating
privately with members of the Board or senior officers of ClearSign regarding any matter in a manner consistent with communications that
may be reasonably made by all stockholders of ClearSign, so long as such communications are not intended to, and would not reasonably
be expected to, require any public disclosure of such communications by any Party or their respective Affiliates or any Third Party,
subject in any case to any confidentiality obligations to ClearSign of any such director or officer and applicable law, rules&nbsp;or
regulations; (B)&nbsp;taking any action necessary to comply with any law, rule&nbsp;or regulation or any action required by any governmental
or regulatory authority or stock exchange that has, or may have, jurisdiction over such Investor Party; (C)&nbsp;generally fulfilling
its obligations to its clients in its role as a broker-dealer or an employee of a broker-dealer, <U>provided</U>, that a breach by any
Investor Party of this Agreement is not the cause of the applicable requirement; or (D)&nbsp;privately communicating with stockholders
of ClearSign and others in a manner that does not otherwise violate this Agreement or applicable law, so long as such actions do not
create a public disclosure obligation for such Investor Party or ClearSign and are undertaken on a basis reasonably designed to be confidential
and in accordance in all material respects with such Investor Party&rsquo;s normal practices in the circumstances. The provisions of
this <U>Section&nbsp;6</U> shall not limit in any respect the actions of any director of ClearSign in his or her capacity as such, recognizing
that such actions are subject to such director&rsquo;s fiduciary duties to ClearSign and its stockholders and the Company Policies (it
being understood and agreed that the Investor Parties shall not take any actions to indirectly violate any provision of this <U>Section&nbsp;6</U>).
The provisions of this <U>Section&nbsp;6</U> shall also not prevent the Investor Parties from freely voting their shares of Common Stock
(except as otherwise provided in <U>Section&nbsp;3</U> hereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>During
the Standstill Period, each Investor Party shall refrain from taking any actions which could have the effect of encouraging, influencing
or assisting any Third Party to engage in actions which, if taken by any Investor Party, would violate this Agreement, except as may be
required by reason of employment in a broker-dealer in the ordinary course.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Representations
and Warranties of ClearSign</U>. ClearSign represents and warrants to the Investor Parties that (a)&nbsp;ClearSign has the corporate power
and authority to execute this Agreement and to bind it thereto, (b)&nbsp;this Agreement has been duly and validly authorized, executed
and delivered by ClearSign, constitutes a valid and binding obligation and agreement of ClearSign, and is enforceable against ClearSign
in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance or similar laws generally affecting the rights and remedies of creditors and subject to general equity principles
and (c)&nbsp;the execution, delivery and performance of this Agreement by ClearSign does not and will not violate or conflict with (i)&nbsp;any
law, rule, regulation, order, judgment or decree applicable to it or (ii)&nbsp;result in any breach or violation of or constitute a default
(or an event which with notice or lapse of time or both could become a default) under or pursuant to, or result in the loss of a material
benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, or any material
agreement, contract, commitment, understanding or arrangement to which ClearSign is a party or by which it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Representations
and Warranties of the Investor Parties</U>. Each Investor Party jointly and severally represents and warrants to ClearSign that solely
for and on behalf of itself that (a)&nbsp;this Agreement has been duly and validly authorized, executed and delivered by such Investor
Party, and constitutes a valid and binding obligation and agreement of such Investor Party, and is enforceable against such Investor
Party in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or similar laws generally affecting the rights and remedies of creditors and subject to general equity
principles, (b)&nbsp;the Investor Parties beneficially own an aggregate of 138,000 shares of Common Stock, (c)&nbsp;the signatory for
such Investor Party has the power and authority to execute this Agreement and any other documents or agreements entered into in connection
with this Agreement on behalf of himself and the applicable Investor Party, and to bind such Investor Party to the terms hereof and thereof,
and to bind himself to the terms hereof and thereof, (d)&nbsp;the execution, delivery and performance of this Agreement by such Investor
Party does not and will not violate or conflict with (i)&nbsp;any law, rule, regulation, order, judgment or decree applicable to it or
(ii)&nbsp;result in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could
become a default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment,
acceleration, or cancellation of, any organizational document or any agreement, contract, commitment, understanding or arrangement to
which such Investor Party is a party or by which it is bound, (e)&nbsp;the Investor Parties acknowledge that neither New Director is
a stockholder designee or representative of the Investor Parties, and the Investor Parties shall not seek, and further acknowledges that
they do not and will not have the right to receive, confidential information concerning ClearSign from either of the New Directors and
(f)&nbsp;each Investor Party is not, nor will any Investor Parties become, party to any agreement, arrangement, commitment or understanding
(whether written or oral) with either New Director with respect to his service as a director on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>SEC
Filings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>ClearSign
shall file with the SEC a Current Report on Form&nbsp;8-K reporting its entry into this Agreement and appending this Agreement as an exhibit
thereto (the &ldquo;<B>Form&nbsp;8-K</B>&rdquo;). The Form&nbsp;8-K shall be consistent with the terms of this Agreement. ClearSign shall
provide the Investor Parties with a reasonable opportunity to review and comment on the Form&nbsp;8-K prior to the filing of the Form&nbsp;8-K
with the SEC and consider in good faith any such comments of the Investor Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Investor Parties shall not make, and shall cause their respective Affiliates and Associates not to make, any public announcement or statement
regarding this Agreement, without the prior written consent of ClearSign, except to the extent required by law or the rules&nbsp;of any
national securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Term;
Termination</U>. The term of this Agreement shall commence on the Effective Date and shall continue until the earlier of (a)&nbsp;the
date immediately following the conclusion of ClearSign&rsquo;s 2026 annual meeting of stockholders (including, without limitation, any
adjournments or postponements thereof and any meeting which may be called in lieu thereof) and (b)&nbsp;the occurrence of a Change of
Control transaction (the &ldquo;<B>Termination Date</B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement,
the provisions of <U>Section&nbsp;11</U> and <U>Section&nbsp;13</U> through <U>Section&nbsp;23</U> hereof shall survive the termination
of this Agreement. The termination of this Agreement shall not relieve any Party from its responsibilities in respect of any breach of
this Agreement prior to such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Expenses</U>.
Each Party shall be responsible for its own fees and expenses in connection with the negotiation, execution and effectuation of this Agreement
and the transactions contemplated hereby. Notwithstanding the foregoing, immediately following full payment of all fees and expenses incurred
by the Special Committee of the Board to its advisors, ClearSign shall pay to Mr.&nbsp;Clarkson an amount not to exceed in the aggregate
$2,000.00 (a)&nbsp;in exchange for the Release and (b)&nbsp;as reimbursement for his reasonable, well-documented out-of-pocket fees and
expenses incurred in connection with the negotiation, execution and effectuation of this Agreement and the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Other Discussions or Arrangements</U>. The Investor Parties represent and warrant that, as of the date of this Agreement, except as described
herein, specifically disclosed to ClearSign in writing prior to the Effective Date and/or are reflected on the books and records of ClearSign,
(a)&nbsp;the Investor Parties do not own, of record or beneficially, any Voting Securities or any securities convertible into, or exchangeable
or exercisable for, any Voting Securities, (b)&nbsp;the Investor Parties have not entered into, directly or indirectly, any agreements
or understandings with any person (other than their own Representatives) with respect to any potential transaction involving ClearSign
or the voting or disposition of any securities of ClearSign and (c)&nbsp;no Investor Party is a member of or a participant in a &ldquo;group&rdquo;
(within the meaning of Section&nbsp;13(d)(3)&nbsp;of the Exchange Act) with respect to any Voting Securities as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law; Jurisdiction</U>. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware
without giving effect to any choice or conflict of law provision or rule&nbsp;that would cause the application of laws of any jurisdiction
other than those of the State of Delaware. Each Party agrees that it shall bring any suit, action or other proceeding in respect of any
claim arising out of or related to this Agreement (each, an &ldquo;<B>Action</B>&rdquo;) exclusively in (a)&nbsp;the Delaware Court of
Chancery, (b)&nbsp;in the event (but only in the event) that such court does not have subject matter jurisdiction over such Action, the
United States District Court for the District of Delaware or (c)&nbsp;in the event (but only in the event) that such courts identified
in clauses (a)&nbsp;and (b)&nbsp;do not have subject matter jurisdiction over such Action, any other Delaware state court (collectively,
the &ldquo;<B>Chosen Courts</B>&rdquo;), and, solely in connection with an Action brought in accordance with this provision, irrevocably
(i)&nbsp;submits to the exclusive jurisdiction of the Chosen Courts, (ii)&nbsp;waives any jurisdictional defenses (including, without
limitation, personal jurisdiction and venue) to any such Action in the Chosen Courts, (iii)&nbsp;waives any objection that the Chosen
Courts are an inconvenient forum or do not have jurisdiction over any Party and (iv)&nbsp;agrees that service of process upon such Party
in any such Action shall be effective if notice is given in accordance with <U>Section&nbsp;17</U> hereof. Each Party agrees that a final
judgment in any Action brought in the Chosen Courts shall be conclusive and binding upon each Party and may be enforced in any other courts,
the jurisdiction of which each Party is or may be subject, by suit upon such judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waiver
of Jury Trial</U>. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE UNDER THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO
THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO
REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING
WAIVER IN THE EVENT OF A LEGAL ACTION, (B)&nbsp;SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C)&nbsp;SUCH PARTY MAKES THIS
WAIVER VOLUNTARILY AND (D)&nbsp;SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS <U>SECTION&nbsp;14</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Specific
Performance</U>. Each Party acknowledges and agrees that irreparable injury to the other Parties would occur in the event any of the provisions
of this Agreement are not performed in accordance with their specific terms or are otherwise breached and that such injury would not be
adequately compensable by the remedies available at law (including, without limitation, the payment of money damages). It is accordingly
agreed that each of the Parties (the &ldquo;<B>Moving Party</B>&rdquo;) shall be entitled to seek specific enforcement of, and injunctive
or other equitable relief as a remedy for any such breach or to prevent any violation or threatened violation of, the terms hereof, and
the other Parties will not take action, directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that
any other remedy or relief is available at law or in equity. Each Party further agrees to waive any requirement for the security or posting
of any bond in connection with any such relief. The remedies available pursuant to this <U>Section&nbsp;15</U> shall not be deemed to
be the exclusive remedies for a breach of this Agreement but shall be in addition to all other remedies available at law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Certain
Definitions</U>. As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Affiliate</B>&rdquo;
shall mean any &ldquo;Affiliate&rdquo; as defined in Rule&nbsp;12b-2 promulgated by the SEC under the Exchange Act, including, without
limitation, persons who become Affiliates subsequent to the Effective Date; <U>provided</U>, <U>however</U>, that, for purposes of this
Agreement, no Investor Party shall be deemed an Affiliate of ClearSign, and ClearSign shall not be deemed an Affiliate of any Investor
Party; <U>provided</U>, <U>further</U>, that the term Affiliate will not include any direct or indirect employees, consultants or agents
of an Investor Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Associate</B>&rdquo;
shall mean any &ldquo;Associate&rdquo; as defined in Rule&nbsp;12b-2 promulgated by the SEC under the Exchange Act, including, without
limitation, persons who become Associates subsequent to the Effective Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>beneficial
owner</B>,&rdquo; &ldquo;<B>beneficial ownership</B>&rdquo; and &ldquo;<B>beneficially own</B>&rdquo; shall have the same meanings as
set forth in Rule&nbsp;13d-3 promulgated by the SEC under the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>business
day</B>&rdquo; shall mean any day other than a Saturday, Sunday or day on which the commercial banks in the State of New York are authorized
or obligated to be closed by applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Bylaws</B>&rdquo;
shall mean ClearSign&rsquo;s Bylaws, as filed with the SEC on June&nbsp;15, 2023, as may be amended, corrected or amended and restated
from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Certificate
of Incorporation</B>&rdquo; shall mean ClearSign&rsquo;s Certificate of Incorporation, dated June&nbsp;14, 2023, as amended on June&nbsp;25,
2024, and as may be further amended, corrected or amended and restated from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>a
 &ldquo;<B>Change of Control</B>&rdquo; shall be deemed to have taken place if (i)&nbsp;any person is or becomes a beneficial owner, directly
or indirectly, of securities of ClearSign representing more than fifty percent (50%) of the equity interests and voting power of ClearSign&rsquo;s
then-outstanding equity securities or (ii)&nbsp;ClearSign enters into a stock-for-stock transaction whereby immediately after the consummation
of the transaction ClearSign&rsquo;s stockholders retain, directly or indirectly, less than fifty percent (50%) of the equity interests
and voting power of the surviving entity&rsquo;s then-outstanding equity securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Extraordinary
Transaction</B>&rdquo; shall mean any equity tender offer, equity exchange offer, merger, acquisition, joint venture, business combination,
financing, restructuring, recapitalization, reorganization, disposition, distribution or other transaction with a Third Party that, in
each case, would result in a Change of Control of ClearSign or liquidation or dissolution of its equity securities or a majority of its
assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>person</B>&rdquo;
or &ldquo;<B>persons</B>&rdquo; shall mean any individual, corporation (including, without limitation, not-for-profit), general or limited
partnership, limited liability or unlimited liability company, joint venture, estate, trust, group, association, or other entity of any
kind, structure or nature;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Representative</B>&rdquo;
shall mean a person&rsquo;s Affiliates and Associates and its and their respective directors, officers, employees, partners, members,
managers, consultants, legal or other advisors, agents and other representatives; <U>provided</U>, that, when used with respect to ClearSign,
 &ldquo;Representative&rdquo; shall not include any non-executive employees; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Voting
Securities</B>&rdquo; shall mean the Common Stock and any other securities of ClearSign entitled to vote in the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices</U>.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to
have been given: (a)&nbsp;when delivered by hand (with written confirmation of receipt), (b)&nbsp;when received by the addressee if sent
by a nationally recognized overnight courier (receipt requested), (c)&nbsp;on the date sent by email (with confirmation of transmission)
if sent during normal business hours of ClearSign, and on the next business day if sent after normal business hours of ClearSign or (d)&nbsp;on
the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must
be sent to the respective Parties at the addresses set forth in this <U>Section&nbsp;17</U> (or to such other address that may be designated
by a Party from time to time in accordance with this <U>Section&nbsp;17</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to ClearSign, to its address at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">ClearSign Technologies Corporation<BR>
8023 E. 63<SUP>rd</SUP> Place, Suite&nbsp;101<BR>
Tulsa, OK 74133<BR>
Attention: Jim Deller</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>with a copy (which shall not constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Sullivan&nbsp;&amp; Cromwell LLP<BR>
125 Broad Street<BR>
New York, NY 10004<BR>
Attention:<BR>
Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to an Investor Party, to the address at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Entire
Agreement; Amendment</U>. This Agreement constitutes the sole and entire agreement of the Parties with respect to the subject matter contained
herein, and it supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and
oral, with respect to such subject matter. This Agreement may be amended, modified or supplemented only by an agreement in writing signed
by each Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>.
If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts</U>.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to
be one and the same agreement. A signed copy of this Agreement delivered by email or other means of electronic transmission shall be deemed
to have the same legal effect as delivery of an original signed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment</U>.
No Party may assign any of its rights or delegate any of its obligations hereunder without the prior written consent of the other Parties,
<U>provided</U>, that each Party may assign any of its rights and delegate any of its obligations hereunder to any person that acquires
substantially all of that Party&rsquo;s assets, whether by stock sale, merger, asset sale or otherwise. Any purported assignment or delegation
in violation of this <U>Section&nbsp;21</U> shall be null and void. No assignment or delegation shall relieve the assigning or delegating
Party of any of its obligations hereunder. This Agreement is for the sole benefit of the Parties and their respective successors and permitted
assigns and nothing herein, express or implied, is intended to or shall confer upon any other person any legal or equitable right, benefit
or remedy of any nature whatsoever under or by reason of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waivers</U>.
No waiver by any Party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the Party
so waiving. No waiver by any Party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly
identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No
failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed
as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or
further exercise thereof or the exercise of any other right, remedy, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Interpretation</U>.
Each Party hereby affirms that it has been represented by legal counsel of its choice throughout all negotiations that have preceded the
execution of this Agreement and that it has executed the same with the advice of said counsel. Each Party hereby further affirms that
it and its respective legal counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred
to herein, and any and all drafts relating thereto exchanged among the Parties shall be deemed the work product of all Parties and may
not be construed against any Party by reason of its drafting or preparation. Accordingly, any rule&nbsp;of law or any legal decision that
would require interpretation of any ambiguities in this Agreement against any Party that drafted or prepared it is of no application and
is expressly waived by each Party, and any controversy over interpretations of this Agreement shall be decided without regard to events
of drafting or preparation. The headings set forth in this Agreement are for convenience of reference purposes only and shall not affect
or be deemed to affect in any way the meaning or interpretation of this Agreement or any term or provision of this Agreement. In this
Agreement, unless a clear contrary intention appears, (a)&nbsp;the word &ldquo;including&rdquo; (in its various forms) means &ldquo;including,
without limitation,&rdquo; (b)&nbsp;the words &ldquo;hereunder,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereto&rdquo; and words of similar
import are references to this Agreement as a whole and not to any particular provision of this Agreement, (c)&nbsp;the word &ldquo;or&rdquo;
is not exclusive, (d)&nbsp;references to &ldquo;Sections&rdquo; in this Agreement are references to Sections of this Agreement unless
otherwise indicated and (e)&nbsp;whenever the context requires, the masculine gender shall include the feminine and neutral genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of Page&nbsp;Intentionally Left Blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B></FONT>, the Parties have executed this Agreement to be effective as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><U>CLEARSIGN</U>:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">CLEARSIGN TECHNOLOGIES CORPORATION</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">By:&#8239;&#8239;&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%">/s/ David M. Maley</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:&#8239;&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">David M. Maley</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:&#8239;&#8239;&#8239;&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Director</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><U>INVESTOR PARTIES</U>:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Richard D. Clarkson</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">Richard D. Clarkson</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature Page&nbsp;to Cooperation Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2516138d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COOPERATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Cooperation Agreement
(this &ldquo;<B>Agreement</B>&rdquo;), effective as of May&nbsp;22, 2025 (the&nbsp;&ldquo;<B>Effective Date</B>&rdquo;), is entered into
by and between ClearSign Technologies Corporation, a Delaware corporation (&ldquo;<B>ClearSign</B>&rdquo;), and Anthony DiGiandomenico
(collectively with his Affiliates and Associates, the &ldquo;<B>Investor Parties</B>,&rdquo; and each, an &ldquo;<B>Investor Party</B>&rdquo;).
ClearSign and the Investor Parties are together referred to herein as the &ldquo;<B>Parties</B>,&rdquo; and each, a &ldquo;<B>Party</B>.&rdquo;
Unless otherwise defined herein, capitalized terms shall have the meanings given to them in <U>Section&nbsp;16</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, on January&nbsp;15,
2025, the Investor Parties delivered a letter to ClearSign pursuant to Article&nbsp;III, Section&nbsp;3.2 of the Bylaws purporting to
notify ClearSign of intent to nominate a director for election to the board of directors of ClearSign (the &ldquo;<B>Board</B>&rdquo;)
at ClearSign&rsquo;s 2025 annual meeting of stockholders (including, without limitation, any adjournments or postponements thereof and
any meeting which may be called in lieu thereof ) (the &ldquo;<B>2025 Annual Meeting</B>&rdquo;) (such notice, the &ldquo;<B>Pre-Nomination
Period DiGiandomenico Notice</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Investor
Parties beneficially own an aggregate of 1,086,956 shares of ClearSign&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<B>Common
Stock</B>&rdquo;), which includes 542,478 shares of Common Stock issuable upon the exercise of outstanding warrants, as of the Effective
Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, ClearSign
has reached an agreement with the Investor Parties with respect to certain matters, as provided for in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the premises, representations and mutual covenants and agreements set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Withdrawal
of the Investor Parties&rsquo; Campaigns and Related Matters</U>. Concurrently with and effective upon the execution of this Agreement,
the (a)&nbsp;Investor Parties (i)&nbsp;hereby acknowledge that the Pre-Nomination Period DiGiandomenico Notice was delivered prior to
February&nbsp;25, 2025, the first date as defined by the Bylaws in which stockholders were permitted to submit notice of intent to nominate
candidates for election to the Board in connection with the 2025 Annual Meeting and (ii)&nbsp;shall irrevocably withdraw or cause the
irrevocable withdrawal of the Pre-Nomination Period DiGiandomenico Notice (with this Agreement deemed to evidence such withdrawal) and
(b)&nbsp;Investor Parties shall irrevocably withdraw or cause the irrevocable withdrawal of any and all outstanding and yet to be withdrawn
materials and notices submitted to ClearSign in connection with or related to the Pre-Nomination Period DiGiandomenico Notice, and shall
take all necessary action to immediately cease any and all solicitation efforts and other activities in connection with the Pre-Nomination
Period DiGiandomenico Notice and any and all related materials and notices (other than in connection with such withdrawal).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Board
Composition and Other Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>New
Directors</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
soon as reasonably practicable following the Effective Date, the Board, and all applicable committees of the Board, shall take all necessary
actions to: (A)&nbsp;increase the size of the Board from five (5)&nbsp;to seven (7)&nbsp;directors, and (B)&nbsp;appoint (x)&nbsp;Louis&nbsp;J.
Basenese (the &ldquo;<B>First New Director</B>&rdquo;) to serve as a director, who shall fill one (1)&nbsp;of the newly created vacancies
resulting from the increase in the size of the Board, and (y)&nbsp;Mr.&nbsp;DiGiandomenico (the &ldquo;<B>Second New Director</B>&rdquo;
and, together with the First New Director, the &ldquo;<B>New Directors</B>&rdquo;) to serve as a director, who shall fill the other newly
created vacancy resulting from the increase in the size of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Board, and all applicable committees of the Board, shall take all necessary actions to nominate each New Director as a candidate for
election to the Board at the 2025 Annual Meeting. ClearSign shall recommend, support and solicit proxies for the election of each New
Director at the 2025 Annual Meeting in the same manner as ClearSign has supported its nominees for election at prior annual meetings
of stockholders at which the election of directors was uncontested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Prior
to the appointment of the New Directors, (A)&nbsp;the Board has determined that the First New Director is an &ldquo;Independent Director,&rdquo;
as defined in the listing rules&nbsp;of the Nasdaq Stock Market LLC (&ldquo;<B>Nasdaq</B>&rdquo;) and (B)&nbsp;the Special Committee of
the Board has determined that the Second New Director is not an &ldquo;Independent Director,&rdquo; as defined in the listing rules&nbsp;of
Nasdaq. In connection with the foregoing, and as a condition to ClearSign&rsquo;s obligation to appoint each New Director to the Board,
each New Director has (x)&nbsp;provided (1)&nbsp;such information required to be or is customarily disclosed by directors or director
candidates in proxy statements or other filings under applicable law or stock exchange regulations, (2)&nbsp;such information reasonably
requested by the Board in connection with assessing eligibility, independence and other criteria applicable to directors or satisfying
compliance and legal obligations and (3)&nbsp;a fully completed and executed copy of ClearSign&rsquo;s director candidate questionnaire
(substantially in the form completed by ClearSign&rsquo;s incumbent non-management directors), in each case, as promptly as practicable
to, among other reasons, enable the timely filing of ClearSign&rsquo;s proxy statement and other periodic reports with the U.S. Securities
and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), and (y)&nbsp;participated in (1)&nbsp;customary procedures for new director candidates,
including, without limitation, an appropriate background check, comparable to those undergone by other non-management directors of ClearSign
and (2)&nbsp;an interview with the Nominating and Corporate Governance Committee of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Committees</U>.
Following the appointment of the New Directors to the Board, the Board, and all applicable committees of the Board, shall take all necessary
actions to appoint the New Directors to the Human Capital and Compensation Committee of the Board, subject to each New Director meeting
the applicable eligibility requirements for committee membership, including, without limitation, a determination by the Board, in its
sole and unencumbered discretion, that such New Director is an &ldquo;Independent Director&rdquo; as defined in the listing rules&nbsp;of
NASDAQ; <U>provided</U>, <U>however</U>, that the Board shall not be required to appoint a New Director to the Compensation Committee
of the Board if the Board determines, or has determined, such New Director not to be an &ldquo;Independent Director&rdquo; as defined
in the listing rules&nbsp;of NASDAQ; <U>provided</U>, <U>further</U>, that the Board is entitled to, and shall, rely on the finding and
conclusion of the Special Committee of the Board which determines that the Second New Director is not an &ldquo;independent director&rdquo;
as such term is defined in the listing rules&nbsp;of NASDAQ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Board
Policies and Procedures</U>. Each Party acknowledges that each New Director, upon his appointment to the Board and for so long as he is
a member of the Board, shall be governed by all of the same policies, processes, procedures, codes, rules, standards and guidelines applicable
to members of the Board, including, without limitation, ClearSign&rsquo;s Code of Business Conduct and Ethics, Clawback Policy, Policy
Regarding Stockholder Candidates for Nomination and any other policies on stock ownership, insider trading, anti-hedging, corporate governance,
public disclosures and confidentiality (collectively, the&nbsp;&ldquo;<B>Company Policies</B>&rdquo;) and all applicable rules&nbsp;and
regulations of Nasdaq, and will be required to strictly adhere to ClearSign&rsquo;s policies on confidentiality imposed on all members
of the Board. ClearSign agrees that, upon his appointment to the Board and for so long as he is a member of the Board, each New Director
shall receive (i)&nbsp;the same benefits of director and officer insurance and any indemnity and exculpation arrangements as all other
non-management directors on the Board, (ii)&nbsp;the same compensation for his service as a director as the compensation received by other
non-management directors on the Board and (iii)&nbsp;such other benefits on the same basis as all other non-management directors on the
Board. Notwithstanding anything to the contrary contained in this Agreement, ClearSign agrees that the Second New Director is a stockholder
designee of the Investor Parties and, as a result, the Second New Director may provide confidential information of ClearSign to the Investor
Parties that the Second New Director learns in his capacity as a member of the Board; <U>provided</U>, <U>however</U>, that, prior to
the Second New Director providing any such confidential information to any Investor Party and as a condition precedent to such Investor
Party requesting or receiving any such information, ClearSign and such Investor Party shall execute a customary confidentiality agreement,
pursuant to which, among other things, such Investor Party (A)&nbsp;is informed of the confidential nature of the confidential information,
(B)&nbsp;agrees that it will abstain from participating in any transaction involving or related to securities of ClearSign while in possession
of material non-public information and (C)&nbsp;shall refrain from disclosing the confidential information to anyone, other than as set
forth in such confidentiality agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Voting</U>.
From the Effective Date until the Termination Date (as defined below) (the &ldquo;<B>Standstill Period</B>&rdquo;), each Investor Party
agrees that it will appear in person or by proxy at each annual or special meeting of stockholders of ClearSign (including, without limitation,
any adjournments, postponements, reschedulings or continuations thereof and any meeting which may be called in lieu thereof), whether
such meeting is held at a physical location or virtually by means of remote communications or a hybrid combination thereof, and will vote
(or execute a consent with respect to) all Voting Securities beneficially owned by such Investor Party as of the applicable record date
in accordance with the Board&rsquo;s recommendations with respect to (a)&nbsp;the election, removal or replacement of any director, (b)&nbsp;the
ratification of the appointment of ClearSign&rsquo;s independent registered public accounting firm, (c)&nbsp;ClearSign&rsquo;s &ldquo;say-on-pay&rdquo;
proposal and (d)&nbsp;any other proposal to be submitted to the stockholders of ClearSign by either ClearSign or any stockholder of ClearSign;
<U>provided</U>, <U>however</U>, that the Investor Parties shall be permitted to vote in their sole discretion on any proposal of ClearSign
in respect of any Extraordinary Transaction. During the Standstill Period, each Investor Party agrees that it will not engage in any course
of conduct with the purpose of causing stockholders of ClearSign to vote contrary to the recommendation of the Board on any of the aforementioned
matters enumerated in subclauses&nbsp;(a)&ndash;(d)&nbsp;presented to ClearSign&rsquo;s stockholders for their vote at any meeting of
ClearSign&rsquo;s stockholders or by written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Mutual
Non-Disparagement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to <U>Section&nbsp;6</U> hereof, each Investor Party agrees that, during the Standstill Period, neither it nor any of its Representatives
shall, and it shall cause each of its Representatives to not, directly or indirectly, in any capacity or manner, make, express, transmit,
speak, write, verbalize or otherwise communicate in any way (or cause, further, assist, solicit, encourage, support or participate in
any of the foregoing), any remark, comment, message, information, declaration, communication or other statement of any kind (including,
without limitation, through the use of any social or professional networking websites and/or blogs), whether verbal, in writing, electronically
transferred or otherwise, that might reasonably be construed to be derogatory or critical of, or negative toward, or constitute an <I>ad
hominem</I> attack on, or otherwise disparage, defame, damage, criticize, condemn or impugn the reputation or good name of ClearSign or
any of its Representatives, former directors and officers, or any of their respective businesses, products, services, actions, writings,
policies or practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>ClearSign
agrees that, during the Standstill Period, neither it nor any of its Representatives shall, and it shall cause each of its Representatives
to not, directly or indirectly, in any capacity or manner, make, express, transmit, speak, write, verbalize or otherwise communicate in
any way (or cause, further, assist, solicit, encourage, support or participate in any of the foregoing), any remark, comment, message,
information, declaration, communication or other statement of any kind (including, without limitation, through the use of any social or
professional networking websites and/or blogs), whether verbal, in writing, electronically transferred or otherwise, that might reasonably
be construed to be derogatory or critical of, or negative toward, or constitute an <I>ad hominem</I> attack on, or otherwise disparage,
defame, damage, criticize, condemn or impugn the reputation or good name of any Investor Party or any of their respective Representatives,
or any of their respective businesses, products, services, actions, writings, policies or practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
the foregoing, nothing in this <U>Section&nbsp;4</U> or elsewhere in this Agreement shall prohibit any Party from making any factual statement
or disclosure as may be required under the federal securities laws or other applicable laws (including, without limitation, to comply
with the terms of any valid subpoena, order or other legal process from any governmental or regulatory authority with competent jurisdiction
over the relevant Party), or stock exchange regulations; <U>provided</U>,&nbsp;<U>however</U>, that, unless prohibited under applicable
law, such Party must provide written notice to the other Party at least two (2)&nbsp;business days prior to making any such statement
or disclosure required under the federal securities laws or other applicable laws or stock exchange regulations that would otherwise be
prohibited by the provisions of this&nbsp;<U>Section&nbsp;4</U>, and reasonably consider any comments of such other Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
limitations set forth in <U>Sections 4(a)</U>&nbsp;and <U>4(b)</U>&nbsp;hereof shall not prevent any Party from responding to any public
statement made by the other Party of the nature described in <U>Sections 4(a)</U>&nbsp;and <U>4(b)</U>&nbsp;hereof if such statement by
the other Party was made in breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Litigation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Each
Investor Party covenants and agrees solely for and on behalf of itself that, during the Standstill Period, it shall not, and shall not
permit any of its Representatives to (solely in the context of their representation of such Investor Party in connection with the subject
matter of this Agreement), alone or in concert with others, threaten, initiate,&nbsp;encourage or pursue, or knowingly assist any other
person to threaten, initiate, encourage or pursue, any lawsuit, claim or proceeding (including, without limitation, the Investor Parties
commencing, encouraging or supporting any derivative or similar action in the name of ClearSign) before any court or governmental, administrative
or regulatory body (collectively, &ldquo;<B>Legal Proceeding</B>&rdquo;) with respect to any Claims (as defined below) against ClearSign,
except for any Legal Proceeding initiated solely to remedy a breach of or to enforce this Agreement; <U>provided</U>, <U>however</U>,
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>the
foregoing shall not prevent (A)&nbsp;the Investor Parties or any of their respective Representatives (solely in the context of their representation
of such Investor Party in connection with the subject matter of this Agreement), from responding to oral questions, interrogatories, requests
for information or documents, subpoenas, civil investigative demands or similar processes (a &ldquo;<B>Legal Requirement</B>&rdquo;) in
connection with any Legal Proceeding if such Legal Proceeding has not been initiated by, or on behalf of, or with the material assistance
of, the Investor Parties or any of their Representatives (solely in the context of their representation of such Investor Party in connection
with the subject matter of this Agreement) or (B)&nbsp;the exercise of statutory appraisal rights; <U>provided</U>, <U>further</U>, that,
in the event that any of the Investor Parties or any of their Representatives receives such Legal Requirement, such Investor Party shall,
unless prohibited by applicable law, give prompt written notice of such Legal Requirement to ClearSign; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>this
<U>Section&nbsp;5(a)</U>&nbsp;shall not require any Investor Party to opt out of any class action lawsuits against ClearSign commenced
and maintained by persons other than an Investor Party and its Affiliates unless such lawsuit was initiated in violation of this <U>Section&nbsp;5(a)</U>&nbsp;(&ldquo;<B>Class&nbsp;Actions</B>&rdquo;)
or the Investor Party is a party other than as a result of the Investor Parties&rsquo; ownership of Common Stock during the class period
applicable to such Class&nbsp;Actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>ClearSign
covenants and agrees that, during the Standstill Period, it shall not, and shall not permit any of its Representatives to (solely in
the context of their representation of ClearSign in connection with the subject matter of this Agreement), alone or in concert with others,
threaten, initiate,&nbsp;encourage or pursue, or knowingly assist any other person to threaten, initiate, encourage or pursue, any Legal
Proceedings with respect to any Claim against any of the Investor Parties, except for any Legal Proceeding initiated solely to remedy
a breach of or to enforce this Agreement; <U>provided</U>, <U>however</U>, that the foregoing shall not prevent (A)&nbsp;ClearSign or
any of its Representatives (solely in the context of their representation of ClearSign in connection with the subject matter of this
Agreement), from responding to a Legal Requirement in connection with any Legal Proceeding if such Legal Proceeding has not been initiated
by, or on behalf of, ClearSign or any of its Representatives (solely in the context of their representation of ClearSign in connection
with the subject matter of this Agreement) or (B)&nbsp;the exercise of statutory appraisal rights; <U>provided</U>, <U>further</U>, that,
in the event ClearSign or any of its Representatives receives such Legal Requirement, ClearSign shall, unless prohibited by applicable
law, give prompt written notice of such Legal Requirement to the Investor Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
the fullest extent permitted by law, the Investor Parties, on behalf of themselves and for all of their Affiliates, Associates, parent
and subsidiary entities, joint ventures and partnerships, successors, assigns and the respective owners, officers, directors, partners,
members, managers, principals, parents, subsidiaries, predecessor entities, agents, employees, stockholders, advisors, consultants, attorneys,
heirs, executors, administrators, successors and assigns of any such person irrevocably, completely and unconditionally release, settle,
acquit and forever discharge ClearSign and ClearSign&rsquo;s Affiliates, Associates, parent and subsidiary entities, joint ventures and
partnerships, successors, assigns, and their respective owners, officers, directors, partners, members, managers, principals, parents,
subsidiaries, predecessor entities, agents, employees, stockholders, advisors, consultants, attorneys, heirs, executors, administrators,
successors and assigns of any such person, jointly or severally, from any and all causes of action, claims, actions, rights, judgments,
obligations, damages, amounts, demands, leases, controversies, suits, contentions, complaints, promises, accountings, bonds, bills, debts,
liabilities, dues, sums of money, expenses, specialties and fees and costs (whether direct, indirect or consequential, incidental or otherwise
including, without limitation, attorney&rsquo;s fees or court costs, of whatever nature) incurred in connection therewith of any kind
or nature whatsoever, foreseen, unforeseen, known or unknown, in their own right, representatively, derivatively or in any other capacity,
in law or in equity or liabilities of whatever kind or character, arising under federal, state, foreign, or common law or the laws of
any other relevant jurisdiction from the beginning of time to the date of this Agreement (the &ldquo;<B>Claims</B>&rdquo;) (such release
by the Investor Parties, the &ldquo;<B>Release</B>&rdquo;);&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that this release and waiver of
the Claims shall not include claims to enforce the terms of this Agreement or the Investor Parties&rsquo; rights under various underwriting
and offering agreements in connection with the public offering by ClearSign in April&nbsp;2024 and February&nbsp;2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Investor Parties hereby acknowledge that, as of the Effective Date, the Investor Parties may have claims against ClearSign that an Investor
Party does not know or suspect to exist in its favor, including, without limitation, claims that, had they been known, might have affected
the decision to enter into this Agreement, or to provide the Release. In connection with any such claims, other than any claims to enforce
the terms of this Agreement or the Investor Parties&rsquo; rights under various underwriting and offering agreements in connection with
the public offering by ClearSign in April&nbsp;2024 and February&nbsp;2018, the Investor Parties agree that they intend to waive, relinquish
and release any and all provisions, rights and benefits any state or territory of the United States or other jurisdiction that purports
to limit the application of a release to unknown claims, or to facts unknown at the time the release was entered into, subject to the
foregoing exclusions. In connection with this waiver, the Investor Parties acknowledge that they, or any of them, may (including, without
limitation, after the Effective Date) discover facts in addition to or different from those known or believed by them to be true with
respect to the subject matter of the Release, but it is the intention of the Investor Parties to completely, fully, finally and forever
compromise, settle, release, discharge and extinguish any and all claims, other than excluded herein, that they may have against ClearSign,
known or unknown, suspected or unsuspected, contingent or absolute, accrued or unaccrued, apparent or unapparent, that now exist or previously
existed, without regard to the subsequent discovery of additional or different facts. The Investor Parties acknowledge that the foregoing
waiver is a key, bargained for element to this Agreement and the Release that is part of it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Standstill</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>During
the Standstill Period, unless otherwise approved by the Board or by ClearSign, each Investor Party shall not, and shall cause its Representatives
not to, directly or indirectly:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>acquire,
offer or seek to acquire, agree to acquire or acquire rights or options to acquire, whether by purchase, tender or exchange offer, through
the acquisition of control of another person, by joining a group, through swap or hedging transactions or otherwise, (A)&nbsp;any securities
of ClearSign, any rights decoupled from the underlying securities of ClearSign, or any derivative securities, contracts or instruments
in any way related to the price of shares of Common Stock, in each case, if such acquisition, offer or seeking to acquire, agreement or
transaction would result in any Investor Party having beneficial ownership of more than 3.5% of the Common Stock or Voting Securities
outstanding at such time, including, without limitation, through the exercise of, or acquisition of, derivative securities or (B)&nbsp;any
assets or liabilities of ClearSign;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>make
any public announcement or proposal with respect to, or offer, seek, propose or indicate an interest in, (A)&nbsp;any form of business
combination or acquisition or other transaction relating to a material amount of assets or securities of ClearSign or any of its subsidiaries,
(B)&nbsp;any form of restructuring, recapitalization or similar transaction with respect to ClearSign or any of its subsidiaries or (C)&nbsp;any
form of tender or exchange offer for Voting Securities, whether or not such transaction involves a Change of Control;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>in
respect of those matters enumerated in <U>Section&nbsp;3</U> hereof, other than as may be required by reason of employment in a broker-dealer
in the ordinary course, engage in, or assist in the engagement in (including, without limitation, engagement by use of or in coordination
with a universal proxy card), any solicitation of proxies or written consents to vote any Voting Securities, communicate with stockholders
of ClearSign pursuant to Rule&nbsp;14a-1(l)(2)(iv)&nbsp;under the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and
regulations promulgated thereunder (the &ldquo;<B>Exchange Act</B>&rdquo;), or conduct, or assist in the conducting of, any type of binding
or nonbinding referendum with respect to any Voting Securities, or assist or participate in any other way, directly or indirectly, in
any solicitation of proxies (or written consents) with respect to, or from the holders of, any Voting Securities, or otherwise become
a &ldquo;participant&rdquo; in a &ldquo;solicitation,&rdquo; as such terms are defined in Instruction 3 of Item 4 of Schedule&nbsp;14A
and Rule&nbsp;14a-1 of Regulation 14A, respectively, under the Exchange Act, to vote any securities of ClearSign (including, without limitation,
by initiating, encouraging or participating in any &ldquo;withhold&rdquo; or similar campaign);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>sell,
offer or agree to sell directly or indirectly, through swap or hedging transactions or otherwise, any Voting Securities or any rights
decoupled from the underlying securities held by any Investor Party to any person who is not (A)&nbsp;a Party to this Agreement, (B)&nbsp;a
member of the Board, (C)&nbsp;an officer of ClearSign or (D)&nbsp;an Affiliate or Associate of any Party (any person not set forth in
clauses (A)&nbsp;through (D)&nbsp;shall be referred to as a &ldquo;<B>Third Party</B>&rdquo;) with a known history of activism or known
plans to engage in activism or that would knowingly (after due inquiry) result in such Third Party, collectively with its Affiliates,
owning, controlling or otherwise having any beneficial or other ownership interest representing in the aggregate in excess of 4.9% of
the shares of Common Stock outstanding at such time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>take
any public action in support of or make any public proposal or request that constitutes or would result in: (A)&nbsp;advising, controlling,
changing, replacing or influencing any director or member of management of ClearSign, including, without limitation, any plans or proposals,
and/or consenting to the calling of any special meeting of stockholders to effect such plans or proposals, to change the number or term
of directors or to fill any vacancies on the Board, except as set forth in this Agreement, (B)&nbsp;any material change in the capitalization,
stock repurchase programs and practices or dividend policy of ClearSign, (C)&nbsp;any other material change in ClearSign&rsquo;s management,
business or corporate structure, (D)&nbsp;seeking to have ClearSign waive or make amendments or modifications to the Certificate of Incorporation,
the Bylaws or the Policy Regarding Stockholder Candidates for Nomination (collectively, the &ldquo;<B>Governing Materials</B>&rdquo;)
or any other actions that may impede or facilitate the acquisition of control of ClearSign by any person, (E)&nbsp;causing a class of
securities of ClearSign to be delisted from, or to cease to be authorized to be quoted on, any securities exchange or (F)&nbsp;causing
a class of securities of ClearSign to become eligible for termination of registration pursuant to Section&nbsp;12(g)(4)&nbsp;of the Exchange
Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>act
by making public announcements or speaking to reporters or members of the media (whether &ldquo;on the record&rdquo; or on &ldquo;background&rdquo;
or &ldquo;off the record&rdquo;), to seek to influence ClearSign&rsquo;s stockholders, management or the Board with respect to ClearSign&rsquo;s
policies, operations, balance sheet, capital allocation, marketing approach, business configuration, Extraordinary Transactions or strategy
or to obtain representation of the Board or seek the removal of any director in any manner, except as expressly permitted by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>call
or seek to call, or request the call of, alone or in concert with others, any meeting of stockholders, whether or not such a meeting is
permitted by the Governing Materials, including, without limitation, a &ldquo;town hall meeting&rdquo;;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>deposit
any Voting Securities in any voting trust or subject any Voting Securities to any arrangement or agreement with respect to the voting
of any Voting Securities (other than (A)&nbsp;any such voting trust, arrangement or agreement solely between the Investor Parties that
is otherwise in accordance with this Agreement or (B)&nbsp;customary brokerage accounts, margin accounts, prime brokerage accounts and
the like);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>seek,
or knowingly encourage or advise any person, to submit nominations in furtherance of a &ldquo;contested solicitation&rdquo; for the election
or removal of directors with respect to ClearSign or seek, or knowingly encourage or take any other action with respect to the election
or removal of any directors of ClearSign;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>form,
join or in any other way participate in any &ldquo;group&rdquo; (within the meaning of Section&nbsp;13(d)(3)&nbsp;of the Exchange Act)
with respect to any of the Voting Securities; <U>provided</U>, <U>however</U>, that nothing herein shall limit the ability of an Affiliate
of any Investor Party to join in a &ldquo;group&rdquo; with any other Investor Party or Affiliate thereof comprising such Investor Party
following the execution of this Agreement, so long as any such Affiliate agrees in writing to be subject to, and bound by, the terms and
conditions of this Agreement and, if required under the Exchange Act, files a Schedule&nbsp;13D or an amendment thereof, as applicable,
within two (2)&nbsp;business days after disclosing that such Investor Party has formed a group with such Affiliate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>demand a copy of ClearSign&rsquo;s list of stockholders or its other books and
records or make any request pursuant to Rule&nbsp;14a-7 under the Exchange Act or under any statutory or regulatory provisions of
the State of Delaware providing for stockholder access to books and records (including, without limitation, lists of stockholders)
of ClearSign;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(xii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>make
any request or submit any proposal to amend or waive the terms of this <U>Section&nbsp;6</U> other than through non-public communications
with ClearSign that would not be reasonably likely to trigger public disclosure obligations for any Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(xiii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>comment
publicly about or disclose in a manner that could reasonably be expected to become public any intent, purpose, plan or proposal with respect
to any transactions involving ClearSign, any director or member of management, policies, strategy, operations, financial results or affairs,
any of its securities or assets, or this Agreement that is inconsistent with the provisions of this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(xiv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>enter
into any discussions, negotiations, agreements or understandings with any person with respect to any action that the Investor Parties
are prohibited from taking pursuant to this <U>Section&nbsp;6</U>, or advise, assist, encourage or seek to persuade any person to take
any action or make any statement with respect to any such action or otherwise take or cause any action or make any statement inconsistent
with any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
anything to the contrary contained in this <U>Section&nbsp;6</U>, each Investor Party shall not be prohibited or restricted from: (A)&nbsp;communicating
privately with members of the Board or senior officers of ClearSign regarding any matter in a manner consistent with communications that
may be reasonably made by all stockholders of ClearSign, so long as such communications are not intended to, and would not reasonably
be expected to, require any public disclosure of such communications by any Party or their respective Affiliates or any Third Party,
subject in any case to any confidentiality obligations to ClearSign of any such director or officer and applicable law, rules&nbsp;or
regulations; (B)&nbsp;taking any action necessary to comply with any law, rule&nbsp;or regulation or any action required by any governmental
or regulatory authority or stock exchange that has, or may have, jurisdiction over such Investor Party; (C)&nbsp;generally fulfilling
its obligations to its clients in its role as a broker-dealer or an employee of a broker-dealer, <U>provided</U>, that a breach by any
Investor Party of this Agreement is not the cause of the applicable requirement; or (D)&nbsp;privately communicating with stockholders
of ClearSign and others in a manner that does not otherwise violate this Agreement or applicable law, so long as such actions do not
create a public disclosure obligation for such Investor Party or ClearSign and are undertaken on a basis reasonably designed to be confidential
and in accordance in all material respects with such Investor Party&rsquo;s normal practices in the circumstances. The provisions of
this <U>Section&nbsp;6</U> shall not limit in any respect the actions of any director of ClearSign in his or her capacity as such, recognizing
that such actions are subject to such director&rsquo;s fiduciary duties to ClearSign and its stockholders and the Company Policies (it
being understood and agreed that the Investor Parties shall not take any actions to indirectly violate any provision of this <U>Section&nbsp;6</U>).
The provisions of this <U>Section&nbsp;6</U> shall also not prevent the Investor Parties from freely voting their shares of Common Stock
(except as otherwise provided in <U>Section&nbsp;3</U> hereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>During
the Standstill Period, each Investor Party shall refrain from taking any actions which could have the effect of encouraging, influencing
or assisting any Third Party to engage in actions which, if taken by any Investor Party, would violate this Agreement, except as may
be required by reason of employment in a broker-dealer in the ordinary course.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Representations
and Warranties of ClearSign</U>. ClearSign represents and warrants to the Investor Parties that (a)&nbsp;ClearSign has the corporate
power and authority to execute this Agreement and to bind it thereto, (b)&nbsp;this Agreement has been duly and validly authorized, executed
and delivered by ClearSign, constitutes a valid and binding obligation and agreement of ClearSign, and is enforceable against ClearSign
in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance or similar laws generally affecting the rights and remedies of creditors and subject to general equity principles
and (c)&nbsp;the execution, delivery and performance of this Agreement by ClearSign does not and will not violate or conflict with (i)&nbsp;any
law, rule, regulation, order, judgment or decree applicable to it or (ii)&nbsp;result in any breach or violation of or constitute a default
(or an event which with notice or lapse of time or both could become a default) under or pursuant to, or result in the loss of a material
benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, or any material
agreement, contract, commitment, understanding or arrangement to which ClearSign is a party or by which it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Representations
and Warranties of the Investor Parties</U>. Each Investor Party jointly and severally represents and warrants to ClearSign that solely
for and on behalf of itself that (a)&nbsp;this Agreement has been duly and validly authorized, executed and delivered by such Investor
Party, and constitutes a valid and binding obligation and agreement of such Investor Party, and is enforceable against such Investor
Party in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or similar laws generally affecting the rights and remedies of creditors and subject to general equity
principles, (b)&nbsp;the Investor Parties beneficially own an aggregate of 1,086,956 shares of Common Stock (which includes 542,478 shares
of Common Stock issuable upon the exercise of outstanding warrants), (c)&nbsp;the signatory for such Investor Party has the power and
authority to execute this Agreement and any other documents or agreements entered into in connection with this Agreement on behalf of
himself and the applicable Investor Party, and to bind such Investor Party the terms hereof and thereof, and to bind himself to the terms
hereof and thereof, (d)&nbsp;the execution, delivery and performance of this Agreement by such Investor Party does not and will not violate
or conflict with (i)&nbsp;any law, rule, regulation, order, judgment or decree applicable to it or (ii)&nbsp;result in any breach or
violation of or constitute a default (or an event which with notice or lapse of time or both could become a default) under or pursuant
to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration, or cancellation of,
any organizational document or any agreement, contract, commitment, understanding or arrangement to which such Investor Party is a party
or by which it is bound, (e)&nbsp;the Investor Parties acknowledge that the First New Director is not a stockholder designee or representative
of the Investor Parties, and the Investor Parties shall not seek, and further acknowledges that they do not and will not have the right
to receive, confidential information concerning ClearSign from the First New Director and (f)&nbsp;each Investor Party is not, nor will
any Investor Parties become, party to any agreement, arrangement, commitment or understanding (whether written or oral) with either New
Director with respect to his service as a director on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>SEC
Filings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>ClearSign
shall file with the SEC a Current Report on Form&nbsp;8-K reporting its entry into this Agreement and appending this Agreement as an exhibit
thereto (the &ldquo;<B>Form&nbsp;8-K</B>&rdquo;). The Form&nbsp;8-K shall be consistent with the terms of this Agreement. ClearSign shall
provide the Investor Parties with a reasonable opportunity to review and comment on the Form&nbsp;8-K prior to the filing of the Form&nbsp;8-K
with the SEC and consider in good faith any such comments of the Investor Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Investor Parties shall not make, and shall cause their respective Affiliates and Associates not to make, any public announcement or statement
regarding this Agreement, without the prior written consent of ClearSign, except to the extent required by law or the rules&nbsp;of any
national securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Term;
Termination</U>. The term of this Agreement shall commence on the Effective Date and shall continue until the earlier of (a)&nbsp;the
date immediately following the conclusion of ClearSign&rsquo;s 2026 annual meeting of stockholders (including, without limitation, any
adjournments or postponements thereof and any meeting which may be called in lieu thereof) and (b)&nbsp;the occurrence of a Change of
Control transaction (the &ldquo;<B>Termination Date</B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement,
the provisions of <U>Section&nbsp;11</U> and <U>Section&nbsp;13</U> through <U>Section&nbsp;23</U> hereof shall survive the termination
of this Agreement. The termination of this Agreement shall not relieve any Party from its responsibilities in respect of any breach of
this Agreement prior to such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Expenses</U>.
Each Party shall be responsible for its own fees and expenses in connection with the negotiation, execution and effectuation of this Agreement
and the transactions contemplated hereby. Notwithstanding the foregoing, immediately following full payment of all fees and expenses incurred
by the Special Committee of the Board to its advisors, ClearSign shall pay to Mr.&nbsp;DiGiandomenico an amount not to exceed in the aggregate
$20,000 (a)&nbsp;in exchange for the Release and (b)&nbsp;as reimbursement for his reasonable, well-documented out-of-pocket fees and
expenses incurred in connection with the negotiation, execution and effectuation of this Agreement and the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Other Discussions or Arrangements</U>. The Investor Parties represent and warrant that, as of the date of this Agreement, except as described
herein, specifically disclosed to ClearSign in writing prior to the Effective Date and/or are reflected on the books and records of ClearSign,
(a)&nbsp;the Investor Parties do not own, of record or beneficially, any Voting Securities or any securities convertible into, or exchangeable
or exercisable for, any Voting Securities, (b)&nbsp;the Investor Parties have not entered into, directly or indirectly, any agreements
or understandings with any person (other than their own Representatives) with respect to any potential transaction involving ClearSign
or the voting or disposition of any securities of ClearSign and (c)&nbsp;no Investor Party is a member of or a participant in a &ldquo;group&rdquo;
(within the meaning of Section&nbsp;13(d)(3)&nbsp;of the Exchange Act) with respect to any Voting Securities as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law; Jurisdiction</U>. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware
without giving effect to any choice or conflict of law provision or rule&nbsp;that would cause the application of laws of any jurisdiction
other than those of the State of Delaware. Each Party agrees that it shall bring any suit, action or other proceeding in respect of any
claim arising out of or related to this Agreement (each, an &ldquo;<B>Action</B>&rdquo;) exclusively in (a)&nbsp;the Delaware Court of
Chancery, (b)&nbsp;in the event (but only in the event) that such court does not have subject matter jurisdiction over such Action, the
United States District Court for the District of Delaware or (c)&nbsp;in the event (but only in the event) that such courts identified
in clauses (a)&nbsp;and (b)&nbsp;do not have subject matter jurisdiction over such Action, any other Delaware state court (collectively,
the &ldquo;<B>Chosen Courts</B>&rdquo;), and, solely in connection with an Action brought in accordance with this provision, irrevocably
(i)&nbsp;submits to the exclusive jurisdiction of the Chosen Courts, (ii)&nbsp;waives any jurisdictional defenses (including, without
limitation, personal jurisdiction and venue) to any such Action in the Chosen Courts, (iii)&nbsp;waives any objection that the Chosen
Courts are an inconvenient forum or do not have jurisdiction over any Party and (iv)&nbsp;agrees that service of process upon such Party
in any such Action shall be effective if notice is given in accordance with <U>Section&nbsp;17</U> hereof. Each Party agrees that a final
judgment in any Action brought in the Chosen Courts shall be conclusive and binding upon each Party and may be enforced in any other courts,
the jurisdiction of which each Party is or may be subject, by suit upon such judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waiver
of Jury Trial</U>. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE UNDER THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO
THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO
REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING
WAIVER IN THE EVENT OF A LEGAL ACTION, (B)&nbsp;SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C)&nbsp;SUCH PARTY MAKES THIS
WAIVER VOLUNTARILY AND (D)&nbsp;SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS <U>SECTION&nbsp;14</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Specific
Performance</U>. Each Party acknowledges and agrees that irreparable injury to the other Parties would occur in the event any of the provisions
of this Agreement are not performed in accordance with their specific terms or are otherwise breached and that such injury would not be
adequately compensable by the remedies available at law (including, without limitation, the payment of money damages). It is accordingly
agreed that each of the Parties (the &ldquo;<B>Moving Party</B>&rdquo;) shall be entitled to seek specific enforcement of, and injunctive
or other equitable relief as a remedy for any such breach or to prevent any violation or threatened violation of, the terms hereof, and
the other Parties will not take action, directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that
any other remedy or relief is available at law or in equity. Each Party further agrees to waive any requirement for the security or posting
of any bond in connection with any such relief. The remedies available pursuant to this <U>Section&nbsp;15</U> shall not be deemed to
be the exclusive remedies for a breach of this Agreement but shall be in addition to all other remedies available at law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Certain
Definitions</U>. As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Affiliate</B>&rdquo;
shall mean any &ldquo;Affiliate&rdquo; as defined in Rule&nbsp;12b-2 promulgated by the SEC under the Exchange Act, including, without
limitation, persons who become Affiliates subsequent to the Effective Date; <U>provided</U>, <U>however</U>, that, for purposes of this
Agreement, no Investor Party shall be deemed an Affiliate of ClearSign, and ClearSign shall not be deemed an Affiliate of any Investor
Party; <U>provided</U>, <U>further</U>, that the term Affiliate shall not include MDB Capital Group, LLC (&ldquo;<B>MDB</B>&rdquo;), or
any direct or indirect employees, consultants or agents of an Investor Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Associate</B>&rdquo;
shall mean any &ldquo;Associate&rdquo; as defined in Rule&nbsp;12b-2 promulgated by the SEC under the Exchange Act, including, without
limitation, persons who become Associates subsequent to the Effective Date; <U>provided</U>, <U>however</U>, that, for purposes of this
Agreement, the term Associate shall not include MDB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>beneficial
owner</B>,&rdquo; &ldquo;<B>beneficial ownership</B>&rdquo; and &ldquo;<B>beneficially own</B>&rdquo; shall have the same meanings as
set forth in Rule&nbsp;13d-3 promulgated by the SEC under the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>business
day</B>&rdquo; shall mean any day other than a Saturday, Sunday or day on which the commercial banks in the State of New York are authorized
or obligated to be closed by applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Bylaws</B>&rdquo;
shall mean ClearSign&rsquo;s Bylaws, as filed with the SEC on June&nbsp;15, 2023, as may be amended, corrected or amended and restated
from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Certificate
of Incorporation</B>&rdquo; shall mean ClearSign&rsquo;s Certificate of Incorporation, dated June&nbsp;14, 2023, as amended on June&nbsp;25,
2024, and as may be further amended, corrected or amended and restated from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>a
 &ldquo;<B>Change of Control</B>&rdquo; shall be deemed to have taken place if (i)&nbsp;any person is or becomes a beneficial owner, directly
or indirectly, of securities of ClearSign representing more than fifty percent (50%) of the equity interests and voting power of ClearSign&rsquo;s
then-outstanding equity securities or (ii)&nbsp;ClearSign enters into a stock-for-stock transaction whereby immediately after the consummation
of the transaction ClearSign&rsquo;s stockholders retain, directly or indirectly, less than fifty percent (50%) of the equity interests
and voting power of the surviving entity&rsquo;s then-outstanding equity securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Extraordinary
Transaction</B>&rdquo; shall mean any equity tender offer, equity exchange offer, merger, acquisition, joint venture, business combination,
financing, restructuring, recapitalization, reorganization, disposition, distribution or other transaction with a Third Party that, in
each case, would result in a Change of Control of ClearSign or liquidation or dissolution of its equity securities or a majority of its
assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>person</B>&rdquo;
or &ldquo;<B>persons</B>&rdquo; shall mean any individual, corporation (including, without limitation, not-for-profit), general or limited
partnership, limited liability or unlimited liability company, joint venture, estate, trust, group, association, or other entity of any
kind, structure or nature;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Representative</B>&rdquo;
shall mean a person&rsquo;s Affiliates and Associates and its and their respective directors, officers, employees, partners, members,
managers, consultants, legal or other advisors, agents and other representatives; <U>provided</U>, that, when used with respect to ClearSign,
 &ldquo;Representative&rdquo; shall not include any non-executive employees; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&ldquo;<B>Voting
Securities</B>&rdquo; shall mean the Common Stock and any other securities of ClearSign entitled to vote in the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices</U>.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to
have been given: (a)&nbsp;when delivered by hand (with written confirmation of receipt), (b)&nbsp;when received by the addressee if sent
by a nationally recognized overnight courier (receipt requested), (c)&nbsp;on the date sent by email (with confirmation of transmission)
if sent during normal business hours of ClearSign, and on the next business day if sent after normal business hours of ClearSign or (d)&nbsp;on
the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must
be sent to the respective Parties at the addresses set forth in this <U>Section&nbsp;17</U> (or to such other address that may be designated
by a Party from time to time in accordance with this <U>Section&nbsp;17</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to ClearSign, to its address at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">ClearSign Technologies Corporation<BR>
8023 E. 63<SUP>rd</SUP> Place, Suite&nbsp;101<BR>
Tulsa, OK 74133<BR>
Attention: Jim Deller</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>with a copy (which shall not constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Sullivan&nbsp;&amp; Cromwell LLP<BR>
125 Broad Street<BR>
New York, NY 10004<BR>
Attention:<BR>
Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to an Investor Party, to the address at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>with a copy (which shall not constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Golenbock Eiseman Assor Bell&nbsp;&amp; Peskoe LLP<BR>
711 Third Avenue<BR>
New York, NY 10017<BR>
Attention:<BR>
Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Entire
Agreement; Amendment</U>. This Agreement constitutes the sole and entire agreement of the Parties with respect to the subject matter contained
herein, and it supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and
oral, with respect to such subject matter. This Agreement may be amended, modified or supplemented only by an agreement in writing signed
by each Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>.
If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts</U>.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to
be one and the same agreement. A signed copy of this Agreement delivered by email or other means of electronic transmission shall be deemed
to have the same legal effect as delivery of an original signed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment</U>.
No Party may assign any of its rights or delegate any of its obligations hereunder without the prior written consent of the other Parties,
<U>provided</U>, that each Party may assign any of its rights and delegate any of its obligations hereunder to any person that acquires
substantially all of that Party&rsquo;s assets, whether by stock sale, merger, asset sale or otherwise. Any purported assignment or delegation
in violation of this <U>Section&nbsp;21</U> shall be null and void. No assignment or delegation shall relieve the assigning or delegating
Party of any of its obligations hereunder. This Agreement is for the sole benefit of the Parties and their respective successors and permitted
assigns and nothing herein, express or implied, is intended to or shall confer upon any other person any legal or equitable right, benefit
or remedy of any nature whatsoever under or by reason of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waivers</U>.
No waiver by any Party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the Party
so waiving. No waiver by any Party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly
identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No
failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed
as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or
further exercise thereof or the exercise of any other right, remedy, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Interpretation</U>.
Each Party acknowledges that it has been represented by legal counsel of its choice throughout all negotiations that have preceded the
execution of this Agreement and that it has executed the same with the advice of said counsel. Each Party and its respective legal counsel
cooperated and participated in the drafting and preparation of this Agreement and the documents referred to herein, and any and all drafts
relating thereto exchanged among the Parties shall be deemed the work product of all Parties and may not be construed against any Party
by reason of its drafting or preparation. Accordingly, any rule&nbsp;of law or any legal decision that would require interpretation of
any ambiguities in this Agreement against any Party that drafted or prepared it is of no application and is expressly waived by each Party,
and any controversy over interpretations of this Agreement shall be decided without regard to events of drafting or preparation. The headings
set forth in this Agreement are for convenience of reference purposes only and shall not affect or be deemed to affect in any way the
meaning or interpretation of this Agreement or any term or provision of this Agreement. In this Agreement, unless a clear contrary intention
appears, (a)&nbsp;the word &ldquo;including&rdquo; (in its various forms) means &ldquo;including, without limitation,&rdquo; (b)&nbsp;the
words &ldquo;hereunder,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereto&rdquo; and words of similar import are references to this Agreement
as a whole and not to any particular provision of this Agreement, (c)&nbsp;the word &ldquo;or&rdquo; is not exclusive, (d)&nbsp;references
to &ldquo;Sections&rdquo; in this Agreement are references to Sections of this Agreement unless otherwise indicated and (e)&nbsp;whenever
the context requires, the masculine gender shall include the feminine and neutral genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of Page&nbsp;Intentionally Left Blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement to be effective as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CLEARSIGN</U>:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARSIGN TECHNOLOGIES<BR>
CORPORATION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David M. Maley</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David M. Maley</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INVESTOR PARTIES</U>:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Anthony DiGiandomenico</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ANTHONY DIGIANDOMENICO</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature Page&nbsp;to Cooperation Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>tm2516138d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>May&nbsp;20, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Re: Board of Directors of ClearSign Technologies
Corporation - Offer Letter</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Louis J. Basenese:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On behalf of ClearSign Technologies
Corporation (the &ldquo;<U>Company</U>,&rdquo; &ldquo;<U>ClearSign</U>,&rdquo; &ldquo;<U>we</U>,&rdquo; &ldquo;<U>our</U>&rdquo; or &ldquo;<U>us</U>&rdquo;)
and our Board of Directors (&ldquo;<U>Board</U>&rdquo;),&nbsp;I am pleased to offer you a position as a member of our Board, including
service as a member of the Board&rsquo;s Human Capital and Compensation Committee, subject to (i)&nbsp;the approval by the Board of the
resolutions authorizing your appointment and (ii)&nbsp;the execution and delivery of that certain cooperation agreement to be entered
into between Richard D. Clarkson and the Company ((i)&nbsp;and (ii)&nbsp;together, the &ldquo;<U>Offer Conditions</U>&rdquo;). We look
forward to working with you on the Board. Should you choose to accept this position as a member of the Board, including service as a member
of the Board&rsquo;s Human Capital and Compensation Committee and any other committees of the Board as may be determined by the Board
at a later time, this letter shall constitute an agreement (the &ldquo;<U>Agreement</U>&rdquo;) between you and the Company and contains
all the terms and conditions relating to the services to be provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Term</U>.
This Agreement shall become effective on the date the Offer Conditions are satisfied and through the date of the next annual stockholders&rsquo;
meeting. Your term as director shall continue until your successor is duly qualified and elected. The position shall be up for re-election
each year at the annual stockholders&rsquo; meeting and upon re-election, the terms and provisions of this Agreement shall remain in full
force and effect. You also agree to resign from the Board of Directors if requested by a majority of the then-sitting members of the Board.
This Agreement shall be in effect as long as you are a director on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services</U>.
You shall render services in the area of managing or directing the Company&rsquo;s property, affairs and business (hereinafter, your &ldquo;<U>Duties</U>&rdquo;).
You shall consult with other members of the Board at meetings held quarterly, or more regularly if required, in locations determined by
the Chairman of the Board of the Company, or if there is no then serving Chairman of the Board, the Chief Executive Officer of the Company.
You agree that your relationship with the Company will be that of a director and not that of an employee. Nothing in this Agreement is
intended to replace, supersede or diminish any of your duties to the Company as a director under state law. You also agree to comply with
all federal and state securities laws as well as Company policies, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services
for Others</U>. You are free to represent or perform services for other persons during the term of this Agreement. However, you agree
that you do not presently perform and do not intend to perform, during the term of this Agreement, similar Duties, consulting or other
services for companies whose businesses are or would be, in any way, in conflict or competitive with the Company (except for companies
previously disclosed by you to the Company in writing). Should you propose to perform similar Duties, consulting or other services for
any such company, you agree to notify the Company in writing in advance (specifying the name of the organization for whom you propose
to perform such services) and to provide sufficient information to the Company to allow it to determine if the performance of such services
would conflict with areas of interest to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
to Independent Directors</U>. In consideration for your service as a member of the Board, you will receive an award of restricted stock
units valued at $15,000 on the grant date, which grant date will be the first day of every quarter that you serve on the Board. In addition,
in consideration for your service as a member of the Board&rsquo;s Human Capital and Compensation Committee, you will receive an award
of restricted stock units valued at $750 on the grant date, which grant date will be the first day of every quarter that you serve on
such committee. The Company may also award additional restricted stock units to you on the first day of each quarter, with values ranging
from $750 to $1,875 per quarter, should you join any other Board committees. These restricted stock units will vest upon death, departure
from the board or a &ldquo;change of control,&rdquo; as such term is defined in the applicable Agreement as determined by the Board&rsquo;s
Compensation Committee and in accordance with the terms and conditions of the Company's 2021 Equity Incentive Plan. The Company will also
reimburse you for reasonable expenses incurred in connection with the performance of your Duties as a director in accordance with the
Company&rsquo;s expense policy then in effect. Should you join the Board or any committee of the Board after the first day of any quarter,
you will receive an award of restricted stock units that is pro-rated for the number of days remaining in such quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>D&amp;O
Insurance Policy</U>. You will be entitled to coverage under our Directors and Officers liability insurance as then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment</U>.
Because of the personal nature of the services to be rendered by you, this Agreement may not be assigned by you. The Company shall be
free to transfer any of its rights under this Agreement to any affiliate or third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Confidential
Information; Non-Disclosure</U>. In consideration of your access to the premises of the Company and your access to certain Confidential
Information of the Company, in connection with your business relationship with the Company, you hereby represent and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definition</U>.
For purposes of this Agreement the term &ldquo;<U>Confidential Information</U>&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
information which the Company possesses that has been created, discovered or developed by or for the Company, and which has or could have
commercial value or utility in the business in which the Company is engaged; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
information that is related to the business of the Company and is generally not known by non-Company personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;By
way of illustration, but not limitation, Confidential Information includes trade secrets and any information concerning products, processes,
formulas, designs, inventions (whether or not patentable or registrable under copyright or similar laws, and whether or not reduced to
practice), discoveries, concepts, ideas, improvements, techniques, methods, research, development and test results, specifications, data,
know-how, software, formats, marketing plans, and analyses, business plans and analyses, strategies, forecasts, customer and supplier
identities, characteristics and Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">b.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exclusions</U>.
Notwithstanding the foregoing, the term Confidential Information shall not include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
information which becomes generally available to the public other than as a result of a breach of the confidentiality portions of this
Agreement, or any other Agreement requiring confidentiality between the Company and you;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Information
received from a third party in rightful possession of such information who is not restricted from disclosing such information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Information
known by you prior to receipt of such information from the Company, which prior knowledge can be documented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Documents</U>.
You agree that, without the express written consent of the Company, you will not remove from the Company's premises, any notes, formulas,
programs, data, records, machines or any other documents or items which in any manner contain or constitute Confidential Information,
nor will you make reproductions or copies of same. In the event you receive any such documents or items by personal delivery from any
duly designated or authorized personnel of the Company, you shall be deemed to have received the express written consent of the Company.
In the event that you receive any such documents or items, other than through personal delivery as described in the preceding sentence,
you agree to inform the Company promptly of your possession of such documents or items. You agree to promptly return any such documents
or items, along with any reproductions or copies to the Company upon the Company's demand or upon termination of this Agreement or your
departure from the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Disparagement</U>.
You agree to forbear from making, causing to be made, publishing, ratifying or endorsing any and all disparaging remarks, derogatory statements
or comments to any third party with respect to the Company and its affiliates, including, without limitation, the Company&rsquo;s parent,
subsidiaries, officers, directors and employees (collectively, &ldquo;<U>Company Parties</U>&rdquo;). Further, you hereby agree to forbear
from making any public or non-confidential statement with respect to any of the Company Parties. The duties and obligations of this paragraph
9 shall continue following the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Solicitation</U>.
You agree and covenant not to directly or indirectly solicit, hire, or recruit for your own benefit or the benefit of any other person,
or so attempt to solicit, hire, or recruit, any employee of the Company, or induce any other employee of the Company to terminate their
employment for two (2)&nbsp;years immediately following your cessation of services to the Company, regardless of the reason. This non-solicitation
paragraph explicitly covers all forms of oral, written, or electronic communication, including, but not limited to, communications by
email, regular mail, express mail, telephone, fax, instant message, and social media, including, but not limited to, Facebook, LinkedIn,&nbsp;Instagram,
and Twitter, and any other social media platform, whether or not in existence at the time of entering into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Disclosure</U>. You agree that you will hold in trust and confidence all Confidential Information and will not disclose to others, directly
or indirectly, any Confidential Information or anything relating to such information without the prior written consent of the Company,
except as maybe necessary in the course of this business relationship with the Company. You further agree that you will not use any Confidential
Information without the prior written consent of the Company, except as may be necessary in the course of your business relationship with
the Company, and that the provisions of this paragraph 11 shall survive termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement shall terminate in the event of your resignation or termination as a director, or your refusal to stand for re-election
or decision not to be nominated or if you are not re-elected for additional terms as a director, effective on the date of your departure
from the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement; Amendment; Waiver</U>. Other than any requirements and duties under applicable law, this Agreement expresses the entire understanding
with respect to the subject matter hereof and supersedes and terminates any prior oral or written Agreements with respect to the subject
matter hereof. Any term of this Agreement may be amended and observance of any term of this Agreement may be waived only with the written
consent of the parties hereto. Waiver of any term or condition of this Agreement by any party shall not be construed as a waiver of any
subsequent breach or failure of the same term or condition or waiver of any other term or condition of this Agreement. The failure of
any party at any time to require performance by any other party of any provision of this Agreement shall not affect the right of any such
party to require future performance of such provision or any other provision of Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Enforcement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Applicable
Law</U>. This Agreement and the rights and remedies of each party arising out of or relating to this Agreement (including, without limitation,
equitable remedies) shall be solely governed by, interpreted under, and construed and enforced in accordance with the laws (without regard
to the conflicts of law principles thereof) of the State of Delaware, as if this Agreement were made, and as if its obligations are to
be performed, wholly within the State of Oklahoma.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">b.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Consent
to Jurisdiction and Venue</U>. Any action or proceeding arising out of or relating to this Agreement shall be filed in and heard and litigated
solely before the state or federal courts of Oklahoma within Tulsa County.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">c.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Attorneys&rsquo;
Fees</U>. If court proceedings are required to enforce any provision of this Agreement, the substantially prevailing or successful party
shall be entitled to an award of the reasonable and necessary expenses of litigation, including reasonable attorneys&rsquo; fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I appreciate your willingness
to serve on our Board and look forward to working with you to serve the Company together. Please indicate your acceptance by signing and
returning the enclosed copy of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -1in; padding-left: -0.125in">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">ClearSign Technologies Corporation</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">/s/ Colin James Deller</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Dr. Colin James Deller, Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: -0.1in; padding-left: 0.1in; width: 50%">ACCEPTED AND AGREED:</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; padding-bottom: 1pt">/s/ Louis J. Basenese</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">Name: Louis J. Basenese</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Date: 05/20/2025</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>tm2516138d1_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>May&nbsp;20, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Re: Board of Directors of ClearSign Technologies
Corporation - Offer Letter</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Anthony DiGiandomenico:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On behalf of ClearSign Technologies
Corporation (the &ldquo;<U>Company</U>,&rdquo; &ldquo;<U>ClearSign</U>,&rdquo; &ldquo;<U>we</U>,&rdquo; &ldquo;<U>our</U>&rdquo; or &ldquo;<U>us</U>&rdquo;)
and our Board of Directors (&ldquo;<U>Board</U>&rdquo;),&nbsp;I am pleased to offer you a position as a member of our Board, subject to
(i)&nbsp;the approval by the Board of the resolutions authorizing your appointment and (ii)&nbsp;the execution and delivery of that certain
cooperation agreement to be entered into between you and the Company ((i)&nbsp;and (ii)&nbsp;together, the &ldquo;<U>Offer Conditions</U>&rdquo;).
We look forward to working with you on the Board. Should you choose to accept this position as a member of the Board, and any committees
of the Board as may be determined by the Board at a later time, this letter shall constitute an agreement (the &ldquo;<U>Agreement</U>&rdquo;)
between you and the Company and contains all the terms and conditions relating to the services to be provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Term</U>.
This Agreement shall become effective on the date the Offer Conditions are satisfied and through the date of the next annual stockholders&rsquo;
meeting. Your term as director shall continue until your successor is duly qualified and elected. The position shall be up for re-election
each year at the annual stockholders&rsquo; meeting and upon re-election, the terms and provisions of this Agreement shall remain in full
force and effect. You also agree to resign from the Board of Directors if requested by a majority of the then-sitting members of the Board.
This Agreement shall be in effect as long as you are a director on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services</U>.
You shall render services in the area of managing or directing the Company&rsquo;s property, affairs and business (hereinafter, your &ldquo;<U>Duties</U>&rdquo;).
You shall consult with other members of the Board at meetings held quarterly, or more regularly if required, in locations determined by
the Chairman of the Board of the Company, or if there is no then serving Chairman of the Board, the Chief Executive Officer of the Company.
You agree that your relationship with the Company will be that of a director and not that of an employee. Nothing in this Agreement is
intended to replace, supersede or diminish any of your duties to the Company as a director under state law. You also agree to comply with
all federal and state securities laws as well as Company policies, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Services
for Others</U>. You are free to represent or perform services for other persons during the term of this Agreement. However, you agree
that you do not presently perform and do not intend to perform, during the term of this Agreement, similar Duties, consulting or other
services for companies whose businesses are or would be, in any way, in conflict or competitive with the Company (except for companies
previously disclosed by you to the Company in writing). Should you propose to perform similar Duties, consulting or other services for
any such company, you agree to notify the Company in writing in advance (specifying the name of the organization for whom you propose
to perform such services) and to provide sufficient information to the Company to allow it to determine if the performance of such services
would conflict with areas of interest to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
to Independent Directors</U>. In consideration for your service as a member of the Board, you will receive an award of restricted stock
units valued at $15,000 on the grant date, which grant date will be the first day of every quarter that you serve on the Board. The Company
may also award additional restricted stock units to you on the first day of each quarter, with values ranging from $750 to $1,875 per
quarter, should you join any Board committees. These restricted stock units will vest upon death, departure from the board or a &ldquo;change
of control,&rdquo; as such term is defined in the applicable Agreement as determined by the Board&rsquo;s Compensation Committee and in
accordance with the terms and conditions of the Company's 2021 Equity Incentive Plan. The Company will also reimburse you for reasonable
expenses incurred in connection with the performance of your Duties as a director in accordance with the Company&rsquo;s expense policy
then in effect. Should you join the Board or any committee of the Board after the first day of any quarter, you will receive an award
of restricted stock units that is pro-rated for the number of days remaining in such quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>D&amp;O
Insurance Policy</U>. You will be entitled to coverage under our Directors and Officers liability insurance as then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment</U>.
Because of the personal nature of the services to be rendered by you, this Agreement may not be assigned by you. The Company shall be
free to transfer any of its rights under this Agreement to any affiliate or third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Confidential
Information; Non-Disclosure</U>. In consideration of your access to the premises of the Company and your access to certain Confidential
Information of the Company, in connection with your business relationship with the Company, you hereby represent and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definition</U>.
For purposes of this Agreement the term &ldquo;<U>Confidential Information</U>&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
information which the Company possesses that has been created, discovered or developed by or for the Company, and which has or could have
commercial value or utility in the business in which the Company is engaged; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
information that is related to the business of the Company and is generally not known by non-Company personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;By
way of illustration, but not limitation, Confidential Information includes trade secrets and any information concerning products, processes,
formulas, designs, inventions (whether or not patentable or registrable under copyright or similar laws, and whether or not reduced to
practice), discoveries, concepts, ideas, improvements, techniques, methods, research, development and test results, specifications, data,
know-how, software, formats, marketing plans, and analyses, business plans and analyses, strategies, forecasts, customer and supplier
identities, characteristics and Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">b.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exclusions</U>.
Notwithstanding the foregoing, the term Confidential Information shall not include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
information which becomes generally available to the public other than as a result of a breach of the confidentiality portions of this
Agreement, or any other Agreement requiring confidentiality between the Company and you;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Information
received from a third party in rightful possession of such information who is not restricted from disclosing such information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Information
known by you prior to receipt of such information from the Company, which prior knowledge can be documented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Documents</U>.
You agree that, without the express written consent of the Company, you will not remove from the Company's premises, any notes, formulas,
programs, data, records, machines or any other documents or items which in any manner contain or constitute Confidential Information,
nor will you make reproductions or copies of same. In the event you receive any such documents or items by personal delivery from any
duly designated or authorized personnel of the Company, you shall be deemed to have received the express written consent of the Company.
In the event that you receive any such documents or items, other than through personal delivery as described in the preceding sentence,
you agree to inform the Company promptly of your possession of such documents or items. You agree to promptly return any such documents
or items, along with any reproductions or copies to the Company upon the Company's demand or upon termination of this Agreement or your
departure from the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Disparagement</U>.
You agree to forbear from making, causing to be made, publishing, ratifying or endorsing any and all disparaging remarks, derogatory statements
or comments to any third party with respect to the Company and its affiliates, including, without limitation, the Company&rsquo;s parent,
subsidiaries, officers, directors and employees (collectively, &ldquo;<U>Company Parties</U>&rdquo;). Further, you hereby agree to forbear
from making any public or non-confidential statement with respect to any of the Company Parties. The duties and obligations of this paragraph
9 shall continue following the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Solicitation</U>.
You agree and covenant not to directly or indirectly solicit, hire, or recruit for your own benefit or the benefit of any other person,
or so attempt to solicit, hire, or recruit, any employee of the Company, or induce any other employee of the Company to terminate their
employment for two (2)&nbsp;years immediately following your cessation of services to the Company, regardless of the reason. This non-solicitation
paragraph explicitly covers all forms of oral, written, or electronic communication, including, but not limited to, communications by
email, regular mail, express mail, telephone, fax, instant message, and social media, including, but not limited to, Facebook, LinkedIn,&nbsp;Instagram,
and Twitter, and any other social media platform, whether or not in existence at the time of entering into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Disclosure</U>. You agree that you will hold in trust and confidence all Confidential Information and will not disclose to others, directly
or indirectly, any Confidential Information or anything relating to such information without the prior written consent of the Company,
except as maybe necessary in the course of this business relationship with the Company. You further agree that you will not use any Confidential
Information without the prior written consent of the Company, except as may be necessary in the course of your business relationship with
the Company, and that the provisions of this paragraph 11 shall survive termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement shall terminate in the event of your resignation or termination as a director, or your refusal to stand for re-election
or decision not to be nominated or if you are not re-elected for additional terms as a director, effective on the date of your departure
from the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement; Amendment; Waiver</U>. Other than any requirements and duties under applicable law, this Agreement expresses the entire understanding
with respect to the subject matter hereof and supersedes and terminates any prior oral or written Agreements with respect to the subject
matter hereof. Any term of this Agreement may be amended and observance of any term of this Agreement may be waived only with the written
consent of the parties hereto. Waiver of any term or condition of this Agreement by any party shall not be construed as a waiver of any
subsequent breach or failure of the same term or condition or waiver of any other term or condition of this Agreement. The failure of
any party at any time to require performance by any other party of any provision of this Agreement shall not affect the right of any such
party to require future performance of such provision or any other provision of Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Enforcement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Applicable
Law</U>. This Agreement and the rights and remedies of each party arising out of or relating to this Agreement (including, without limitation,
equitable remedies) shall be solely governed by, interpreted under, and construed and enforced in accordance with the laws (without regard
to the conflicts of law principles thereof) of the State of Delaware, as if this Agreement were made, and as if its obligations are to
be performed, wholly within the State of Oklahoma.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">b.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Consent
to Jurisdiction and Venue</U>. Any action or proceeding arising out of or relating to this Agreement shall be filed in and heard and litigated
solely before the state or federal courts of Oklahoma within Tulsa County.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">c.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Attorneys&rsquo;
Fees</U>. If court proceedings are required to enforce any provision of this Agreement, the substantially prevailing or successful party
shall be entitled to an award of the reasonable and necessary expenses of litigation, including reasonable attorneys&rsquo; fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I appreciate your willingness
to serve on our Board and look forward to working with you to serve the Company together. Please indicate your acceptance by signing and
returning the enclosed copy of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ClearSign Technologies Corporation</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">/s/ Colin James Deller</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dr. Colin James Deller, Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCEPTED AND AGREED:</B></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Anthony DiGiandomenico</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Anthony DiGiandomenico</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: 05/20/2025</FONT></TD>
    <TD>&nbsp;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>tm2516138d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><IMG SRC="image_001.jpg" ALT="ClearSign Logo" STYLE="height: 77px; width: 338px"><BR STYLE="clear: both">
</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ClearSign Technologies Corporation Announces
Changes to Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TULSA, Okla., May 27, 2025</B> -- ClearSign Technologies Corporation
(Nasdaq: CLIR) (&ldquo;ClearSign&rdquo; or the &ldquo;Company&rdquo;), an emerging leader in industrial combustion and sensing technologies
that support decarbonization<B><I>,</I></B>&nbsp;improve operational and energy efficiency, enable the use of hydrogen as a fuel and enhance
safety while dramatically reducing emissions, today announced that the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) has
voted to expand in size from five to seven directors and it appointed Anthony DiGiandomenico and Lou Basenese to fill such newly created
vacancies and to serve as members of the Board, effective as of&nbsp;May 22, 2025. Further, on May 27, 2025, David M. Maley, a member
of the Board, notified the Company that he will not stand for re-election upon the expiration of his term at the Company&rsquo;s 2025
annual meeting of stockholders. The Board has not yet determined whether it will reduce its size or nominate a replacement director at
this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;I am very pleased to welcome both Anthony and Lou to the Board,&rdquo;
said Jim Deller, Ph.D., Chief Executive Officer of ClearSign. &ldquo;Both have been long time supporters of ClearSign. Their existing
knowledge of the Company and its technologies combined with their capital markets experience and industry connections will make them valuable
and productive additions to the Board. Additionally, David Maley has indicated that he will not be standing for re-election on the upcoming
annual meeting of stockholders, and we thank him for his service to ClearSign.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. DiGiandomenico has been working with and enabling investment into
early-stage disruptive technologies for most of his career. He has worked alongside a wide range of companies in biotechnology, medical
devices, high technology, and renewable energy spaces. Mr. DiGiandomenico currently serves as the Chief of Transactions and director of
MDB Capital Holdings, LLC (NASDAQ: MDBH), a broker-dealer and financial advisory firm based in Dallas, Texas, which he co-founded in 1997
as MDB Capital Group, LLC. Previously, he has served on the board of directors of Provention Bio, Inc., a developer of multiple drug therapies,
from January 2017 until May 2020 and the board of directors of Cue Biopharma, Inc., a company that develops novel biologic drugs for the
selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders, from January 2016 to October
2019. Mr. DiGiandomenico holds an MBA from the Haas School of Business at the University of California, Berkeley and a B.S. in Finance
from the University of Colorado.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lou Basenese brings over 25 years of experience in equity research
and analysis, investment banking, strategic planning, thought leadership development and communications. Mr. Basenese currently serves
as Executive Vice President &ndash; Market Strategy for Prairie Operating Co. (Nasdaq: PROP), a Houston-based publicly traded independent
energy company engaged in the development and acquisition of oil and natural gas resources in the United States. He also serves as CEO
and Chief Strategist of The Basenese Group, LLC, a full-service equity research, strategy, and advisory firm. Mr. Basenese also serves
on the board of directors of ENDRA Life Sciences, Inc. (Nasdaq: NDRA), a life sciences company that develops technologies to improve the
capabilities of clinical diagnostic ultrasound, and the board of directors of The Roberto Clemente Health Clinic, a U.S.-based non-profit
that provides affordable access to high quality health care and wellness programs in the Tola coastal communities of Nicaragua. Prior
to his current roles, Mr. Basenese served as President and Chief Market Strategist of MDB Capital Holdings, LLC (Nasdaq: MDBH) and in
various analyst, strategist, and account executive roles in the financial services and research industries. Mr. Basenese holds an MBA
from the Crummer Graduate School of Business at Rollins College and a B.A. in English from the University of Florida.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About ClearSign Technologies Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ClearSign Technologies Corporation designs and develops products and
technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial systems, including&nbsp;operational
performance, energy efficiency, emission reduction, safety, the use of hydrogen as a fuel and overall cost-effectiveness. Our patented
technologies, embedded in established OEM products as ClearSign Core&trade; and ClearSign Eye&trade;&nbsp;and other sensing configurations,
enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil
production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more
information, please visit&nbsp;<FONT STYLE="color: #0563C1"><U>www.clearsign.com</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matthew Selinger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Firm IR Group for ClearSign</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 415-572-8152</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0563C1"><U>mselinger@firmirgroup.com</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>clir-20250522.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWauNybOdzZR+CYkxtmBybQkary0pV8fxBioq5DwWEecJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:clir="http://clearsign.com/20250522" elementFormDefault="qualified" targetNamespace="http://clearsign.com/20250522">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://clearsign.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="clir-20250522_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="clir-20250522_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>clir-20250522_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>clir-20250522_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://clearsign.com/role/Cover" xlink:href="clir-20250522.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://clearsign.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !- 5(# 2(  A$! Q$!_\0
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MU<=3#V,EHI:'CW@;X=7FN7D5[JD+P::C;R)!AI_8#KCU->Y(JH@50%4#  Z
<4N*6L*E1U'=FL(*"L@HHHK,L**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 22,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLEARSIGN TECHNOLOGIES CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001434524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2056298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8023 E. 63rd Place, Suite 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tulsa<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">74133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">236-6461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLIR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2516138d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://clearsign.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>clir-20250522.xsd</File>
    <File>clir-20250522_lab.xml</File>
    <File>clir-20250522_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2516138d1_8k.htm">tm2516138d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2516138d1_8k.htm": {
   "nsprefix": "clir",
   "nsuri": "http://clearsign.com/20250522",
   "dts": {
    "schema": {
     "local": [
      "clir-20250522.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "clir-20250522_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clir-20250522_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2516138d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://clearsign.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2516138d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2516138d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-052998-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-052998-xbrl.zip
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M-Q"02NZ7D:7 +$W4 -8+25OJ_'0#,-LZ]3!T07$"F(-/22J]7U(6CX12=3L
ML_X!Q29V30MLV.2EK0R*&- >R$P>@<J0<+"Y?%&K<[E,&MC8FMXG/"W;7?Q4
MXF 1,AT.I"@/0RK.$TFUVQ ]#+64KND!K)K<&+*@B+%[ UDIY"C7^X?DDL6#
M$*ET?@ Q;-KQ*$4!PM%TUH>&5/L$XRI)(TP++U=R6]K1/(O6-2"@71.2EC H
M4"!W("Q%@&8F#_$*S+\(%L-PJ2G]P-*R:D>ED@4(BNFM#Q.E]P+);"M$PS4\
MX\!29S=E>\Q6]V<!71"@])AKW;4MY U0/,U ERQ+LKUZG.YFNUD186E<6^**
M#<B<9L(L#X(%P)3)0"%#2H<*H9>>UW<)6*8>8@2;8\K<$F WV:2@J0F(!*LQ
M@(:#-G^FU L1,SDR"4SG+":[7\@>;%=+YY8)P&83"D,4$!5V9P 6I1CE:B3E
M7L"X$\D&B_TBB7JFBK;0+1J0T28;IBH@. !K !VE&BWF,Y\SR1+OYK$$-7E(
MBN?!>R@!]6YAZ;'=9 80!X1.MT. (!F$FE$^09JSB(MG7GO<8<:W<@#<SW@,
MKU!ZHMQ"-:@)3;0Z0P(";(A/ +-&Z(?BF13$U6L\>05(U>"%N(LXE@<J+?^Y
M3A@Y =MOU;JEJ\-NDRF+,""28'< /Z7R@_Z 5 RZ9:% ,WU#4Z?^H9D.A68:
M-#33]T"S?.6!0'/ZAJ:>^H?F="@TIT%#<_HN:&3'>QUK9O+CK5CR5]O#V:#2
M"S)MJU9@#K+P<&EYZX-%!:CUC KQB4F^L+H5=X*_)"R"E\R0W LP@&DK-88V
M/'3L!OOXJ1;$.L[K6%,LRGN_)%KF9Y1IFK0/,84F/$B:QGH'ET+M$XD[GF:8
M_CMY[CP1MXN]X&$U;(6DH0P/%9N]/F"*&"2#?)Q8E[BJ&QK65\F,<G>O %ML
M'5X!KA4& 8'-4?L5X.+J22%RW<V*44$P,"(TBYUULL54U<>ULC"ZN&VHU</Y
M]UIJ?'R15787>O?(&?R 0%OBJJ<A<[JWS?(@>APP9?9Z+D.YSM/5>)5A(K4/
MW[4R9S.[::>:R'5!$+UKNFE-T[K<<6_^+I),[GG&-YLM*^_RV)X;!'2N>KG3
MINYQJRB(WN]R9I)0:E%3[!B+!:=)E&0)6_\J3SY%@FVMLHE< 0$;U#2T%4&@
M -HR.3@(D58ZAN!.$ 4AD1V1OP2H$@N)VX<'ZVS?)78%1;]A#0>L# *27GLF
M+#)@'-4B4!&"\AB_V,S3=$O$F^"QA'A""#0/@-32AX@39+(7JB+0)UL+$FWE
M_+@_F:Z6249M)Y=MB;,Y"3!7S4A&>1!L *9,%O(RQ!_0R?3OJW\@'>6X^V_X
M4F"5.W:QWZPX!;)/656N(.BPJ#FP2()  ?9ETG##42E%A=9'=JJ&64MSC')7
M %AMZ:YO% ;1Z39'K2]_HZ\]#?F7N^A1FB+ "PEVF>NAWV;2'/[KFB 0Z##6
M.BDII4AK?;R0<)BRUOV+@+6W1<"Z9Q&P#G$1L!ZZ"%A[6P3HW18I0N2X=+NB
MR1H#R0D[U:ZAZ+!L\F&1!H4*[ \<,ZH0=(AQG=$R3W&FTO.+3;[_*_G!TDI
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MZ_K74 K0N-J>P59H#U)J-.R,!RR8"!/#)HO9+@.- 0+CKSTO_X2\[PAXY#B
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MS0';R=TMBT.UP8O56D(B4H5&)0^U1J4D!_XC$8\@$;KP=>$+5,?8BT<%?70
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MQUNXTZ&6C\8^B7OZ+8UT2H#,EU"N; $Z> 07"(J3!$7OQ<*P ST9 ,<'^;0
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MA5^T $&JSI8XF)'D;R:) '@ZX([#8<*>F/%(+,^!KD#+:)^UDA'MDZB%&RP
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MMXFTTMQBON[T-!'_.N*=AIYZST([1UUCF2C8P!D7['1UNV1TB>N2%MFZR87
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M<A":\_C^P<4#9 ]U04Y"S@D::"HC/@.4D+?R'"X&A^W\)V,?S=&!/$[F9%/
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M 67$M3N32H-)X$15:2FWC'1M1AIOKE[0,@\7/LC#KBR#)SO1+FZVS;Z 7Y^
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MVV\M(1IS:[_'3MXX5^P;P!%P4HEQ$:F/Z(P2E,Y)=(4(%RN8J"9-FL1E1$K
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MF/)4%Z '4DV^RJ1LUA1;TKL-B  3,SU$VALSNEU5Y-(<W,UY"/'IZ"RE\H8
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M.C_:Q>500!=I:BVR:XZBUG)6C)"8/);R!P427IZ@7[SJK@![IGRYXM)Y>+Y
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M0_C\1W (3ST_^VUP?O%'\/NOQW#_VX,_>$,.SH\O!L'[TZ/!.5Q_?,'WOAW
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M[Z@S6(H'-D\^9(R&4*0+NRUI%'D'X2]H,6B?(R)@7P(SCTV@% 8#"HII.4W
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M-(G1SS&?(FL<F" 1A:D0)!S!OQ_!A=:?\(%(RH-&"MA#X+* *1-_C&@KA"M
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M[NI"F3M-V!,1<'4!)B11+.A,<J=MQBV]VW)"2&DG?(C46&=6Q*K(4XY%^FB
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MX!C:??!A'U^.'3RGCK2GYM7OD=I[=X*R04,$/Q^_.2.95^\^G'^ ?O*[:>[
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M/+65J8DTHTM;()G9'U+5ABZ#U43E[;ZO!;"N$K8WK />B +[&.:@^7MYS:)
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MHZFQQVT6,0T7!FZ \*Y AVB2W<D"HI5-5ZH4;@U,*N2DB0.-'<&N?^>$!ND
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M7Y'3".">MTT>2*TQ<Q]A^LQC[PF?C 57@F$#N8\DY"'!=&&QEN5CY?DP>@W
M9D"(DWPZ,!I&(_!(+FT<[D174J2ZS-EWH4=X'NS==>6#D#.@ 8]!2<?G?SMT
MF.)[(+BH3CDOW8-%[+@ BX$1SGD-&@N" Z532+J\8_#!7 /T[6TNQR""3T/^
MUS;<=,H>E!C\4PWBF^FT24I_5D7MLU[T\C(-#HLF +E3]T$BWTCO4.=> @',
M6-&!.O@M!T\WPI 8/"K+-]=<V7]6_MQ%>(L%IF0LB8'901)NZMQ)R,'JXJD<
MS4C79@ KR" *-6O?"?5:J7 .?,@TCOC-FAC>"(,L]O;DH< A"4$D5=(TC6KA
M*Q@@>O&-,_]**1K;06L*,A#$)3[-%1^A;(N.9";I12U-XMX<.453Q8+5K1AV
M'ITC PB9^GH&([EMLG%T>''TO]>4OE*H)4>*P?JC)MO_=[ASL<8W@-[3>WKQ
MW]5F>O%GF^F/MI 7]%Y.E=+I/*I[8,40U!S+=.3?FO<_M.\K):=CS*VX[S65
MS:/=I@N_%G-;7-'K2ZDNFS:P^;V5(<_"DI)_71W.+N*(2>@3@USPJV=P]KTQ
MF_PNR#7:GYOCD\MS<7I^>7EU?'9V\>:?_]C8W:#/UU?'I^%SD$O6.NSMR]*!
M:(;?#H!(635&A';_!C;S ]Y%C2^X?A< 0 Q; ?'RP&@6[HT@KS=GX48/[N7N
MW]H=W9S==]_CL5IN(CJBMK6GBP-0S S=QU:NAOC=[O;>/DG@SSC7!(%V3A./
MUB6$&_SOW0?O]][-W6O:ENL((KF(.GW9(>1ZD,5G\NR#6="\ GKYFY%%]&+D
M/X;2:R;5_<[M8P6Y$8C ^\9SX(9VW [0$<RD^$GBDI"KY5CB7*,L?+08G(&Q
M7<0U6?56P'@3\ ,-WJ/?3O^5FL<%RT!?3!46+E@)/]%8-#LB"WQ\>GI^=7-^
M)H[?P'__?'=^?O;J(7O\Z3ITOQG\4(NW5'(_":_'J/%*\XUHWJ.J"^_!7],>
M'L1QXXA#WB^$$!@#"+6 GR]W]G=W^,\\/ QWJ1'XM,AT+@A]?$+T332,=RE=
M]=^0%7WS^*QHC2G*^H+J'?S#+/R76O /NOP_4$L#!!0    ( )*"NUK:SY)*
M818  "AJ   6    =&TR-3$V,3,X9#%?97@Q,"TT+FAT;>U=Z6\;1Y;_3H#_
M0ZTWXY$!ZK <Y[ T F1+3C3PV$:LR2!8[(=B=Y&LJ-G%='6+9O[Z_;WWJOK@
M82F.E#A<!W DLKNK7KW[;!U_?_FO5R?]WO'WYZ=G^*GHO^/+B\M7YR?'^_(3
M5_?#Y>/G;\Y^4N\N?WIU_H\'(Y>7S]3C@UFI+NW4>/7:S-4/;JKS@7PQ4.],
M84</\" >?1N?F^IB;/-GZN!(E>9]N:LS.\;'PHXGY8.3X^<GY^\G=FA+++WW
MY?'^<P#R=M,2#TX>YD,_.UJ]Y;;0':EZ,=RZ$:9_Z87L='@P4(<'AT_7 _:1
MN][S,7ZN?&E'"S[(\;]/?C#/U'.GBU2YD3JSA4E*5WCZ\"(SNGB'9]2E22:Y
MR]S8&M_OO7#%S!6ZM"Y7N^K-:&0*]<J4I2F.]_]]\I=$Q1E.JD[S<N+R!9#P
MG=5YZJ8FMXE[]A<[3/C2YJFA10_VGMK\P<F;7 W-1&>CVQ)VIYP8]3!+?ZG<
M$;CDA9O.=+X@ @\>%OQM^VI<<,/UN=EPP57,,_&"*UK7*M^Z]*C? TD4[E_'
MK#O-4WRU_>! D'ZA]%3- *<WJ2H=GB>V7;A*:35SWO*AM<>GJ9D.<0D;U+L-
ME*^&/V,S/-GO[=A'LB:A2,]FA;O6F1HN%'VNH:,/A?$NJVAI+%R!NPK[J\W'
MM&U!3SJ;E^"R4M'9=FQ[7?/>))4 A6NIR>RU*1:RL"Y58HI2V[S?2YR;F4 S
M/2Z,X?5PP"'6R"&3."YVH<_EW)A<CHPE:9- 5;53'VD)$#<VN*\8J"XWB,R_
M<'G*>.L0:J_?^X]1F7-7:N2*.6$#N\]=<44GG]MRPB  W!I=>^K=Q%59RA>2
MB7/>T#,Z20S8O)Q8OY%$]1H#/A0=)G'3J84V(HYNWT&/3O6"$),:(&9J<^"F
M0S8@5JM,XZ(J(78#V3MCW:8\Q"?#ZCG$K*Q*D+Z-\25Y.8T7NCS\(2+09ZQ.
M9,49L15=)#A]O!2P#;8"C(1-((EN\J:XM@G4AI"=&-*F)MW;"LWU>._A?W]S
M^.3;HSO] 1)= K5$'3#L)9&Y)EF@]-" DR!$X/6DA/1%EDW!'_S+LA0H78 6
MH(P?69,&^A:N&D^:YP)#YC@H;L@K* Y?NN1JXK+4%/YAX8E3^KVI,43A/?43
MJ0KB F+?-&B\AA=Q4V54A9^9:!5?06J\QSTX4EIE"_4+-K$U1";#"N -=0DP
M:JF*)U;5C*06'+;+-^):OV=T IDE"ZE+AGXSX"K S5M5,ZS<6FFPQ-',IYXQ
MQVA90X/"3"$.4&!J5&59OP?8$B/G8+(P?B LWHDHD@1 Z9)I&Q5NVM7(C;VP
M(]SU2V5\*1H &D7_#.5<+B*!\"_?!7+X,*)N?$??;.8:@E:@(Y)ECK#A1>+!
M'[HA8D<%;H6L'MZ7K+X+&B[(*Q$],@@@*!H-: 6GP+0F<N%L>DPD!+H%[ZPV
M&ZT;^-83,\*.E@O8D=%(VT)8=%AY6 D/#P-6T-A<CTJRABQIC;(_@Z$VRT:P
M@9%,1I658OL<V=.U'$72%<3'JXF!.83D%M@O U" ?^H*\BC&5:;Q5>1A' JV
M#\?.7*)%#76L6[_'IYW@2$!&=\/P(:""-['\%38":^=L77)!+M"V=A$1ZA<3
M:T;J7'R6:U:-($>QM$/ 2I!4<F,8D6+. /G$S@1);;,XMR)5?#_6:PD042AW
M97,)@C>=96YAS)YZ#4P3U,P1'4&U< S@$A'GI*(P9IE.##EY8 'XAT;8!2BT
M?L(^!19G4%.F=+2[M>7V;:@JX<B2U'VFY^M4% S++%OP6>'7XGPC;%I I=*)
MY$D/5$(AT6Y8Q-,><X,[\3-N.W.932R)+0$PF^&3'F9F.U3)D_M6)6Q,U!OB
M=E$K0B>P_J@V)#/8$N(8W C.P/W31M/0TR+,Q#0L=R!8T"YLL%>,VI[ZWLW-
M== @P@XDGR((*G7,S6%3\$?<DR, N2A\2]"%BX.;MP5C@Y>A-90HJD'42$$Q
M\BGZO<[)$N8QXK[YA-SQJ B->#FX8\X>^]"P\F%!U0O^'8N/P(J,-5H&&HUU
MPHID[YCW[.!W]NOW</YKZRH/!*36)YGS8J0)14N"A]WF)"3Y^%$GAB!E'H*(
MFFXWHZ!#6XHW%^1-30)LBQ;1:&%0 \R[ 1S&27JM<W@K.WYF$MP:B93K:>T'
MNF*,4_\JX1OA =B>MH\ ]FB=@:")0#X2!]-%=Q]72>E:UG YW2^K+J&,XJHL
M<W-E.4JL;470_'$OAAQ =K;L]X3H-869I&1KV9)9#C=]N;3E=NBC+^]+'Q&6
M3.ZU^-I W04VGAG>O7%914-=L'1YF\:(GUA&W'XAT0?"8V(JMJ58T9 \4O@Z
M#VX D:VP%!B(5]_O5;DMO;K66678,_GB\=/!P<%!=%K'A09X%-(,P+,63-)\
MTS+94*9PI>AKMJ&&<QC!K:D]  ;>+&4$+AL&0C2$Q\6",L ZE8A+9RN *X$;
M:&PE&;HP4#030!@(!_,I$5;KG'U%CAR^^/KI 2WSQ>/!-U\_);'H]^JG?*-J
M?G9!_8E+U20?^ C>;(*0<71-TL)A4FIT.8$N-S-L4;$1"N'+4%PU>#O1XTPF
M -1P<H,BP,)E=68-Y&>)94-  : 9L1\8W>+:26BY0]IORH?4SG&;1^F#')$5
M$.6@=)*X(F6542OYM8F+KCOX=T^Y\\?J'%XL(J\+/)^SI7B;Z;S# 8(MY@!X
MX=-A!2^-L2^QJH;YI4,A5'U/<'(< /=)<E\$0"X1: />DIIC&1+3L.3-$777
M'&\Y? @;BT\F3G?>!((=X\0<TW+"BV[6:BDF&(FD+#$Q/5%SXT;)9A;9)"$D
M?);CGETH$UPE7+)]JJ+VP&8^A.#!IC%SA8VW0Z\_O2^]?O903V=';_J]"S@:
M!7//6V:.QMF,>I+8OLPD&$D<=*0>FQ!&,%_6>0L2IQ!:(2RP>F@SDAQ;[Z"]
M6N*\3Y=(#YHRT7_M[JJ7%B'O,_469S_"_;]4!@?"LD?J1U+/S]2AVMT-1<GC
MLXL?N]6_W=+-<//AK(R[[ Y=6;KI,_45?3>$!)NB_NXY KXK]1A@>- D!2B7
MI\]?G:L7YZ]>O3T].[MX_=T_'AP\X,_OWIZ^B)_#GF&UQ&69GGG %G\[ DW3
M<D+8./C;D2+,['K[JQ'TT#8_Q#5 YA*Z.(M<B@-TV38S(W[B+#X1EGYZ\+>&
M%I=GZ^]86[EL/[1_^0/]CTZ-G\#G&M0.H5JO=H<&F@$GF#%EVNC^:@VVB02
M>K4X.RO;'-39LD7^?:*_$/I3Y-G?H%B^NB_%<NHIOQEK"WO]WG.3Z,K7AD/"
M4?A&N69/(GR]5"20Q%D=60V6DR3D<E' .22E0AO6MW8M<\QZ(IP.@5$)5>0I
M,QX2)V1MF %]T&E+.U%$0DD4Z#6HM)*#2]P"XT>^T):$#U_?7_B0CRQM975&
MMJ8._([4:Y?OGDD$#3[8$$%$YT=SV2"&;HC!IY;\J*['Q@9HZ?90B50; 5E)
M,ZYQR7C-.MGZP82@^#N4HP0[-BD:KOYQ;*XI?J<0UV]'Z5[?FX="P0%[YD&1
MO*0\5U50WF%=2:;.,+7; AJBJQ;-VT7]J8$^V Y2V'LA1?AQ2I%N.W,C<75;
M_$ 9+TDX=M\G8/4AE9,3&.J2Z@"4,",'TG!<D2+>SMQ,-#<^1P^_EB02&MF%
MEN(T'$4I$WUMJ+-@.C5%0I3E )FN(T(*'J?$IE%B[3IHP3PF'\.>I]39L1T,
M<#\<L$+Z&)VQ)I3 H(/O-6H9=X]-3E6$3"SW5>[F.5$^AQVH.8B=@]QDVV%6
M[5T3Y#D(,9<8&\$9MA8S.0#J2\9J9A&FA^\V:3_*/F152F):Z)1K.84I?=VA
MTJ8T+"$L*,?7",73*BF!%?R6L)P/N$HQK3+M*3E$?I@G WI-FU)&96<^X0X=
M$DXN'H!=\I(S/)P:&5LZ GT4WRMQLP4[8W0YYL2IP!2506<UZ)$J8?:CM+R&
MP4[,HT;+Q$0Z9?$)K-00F'9*&6DV&?A44H>9I5K[ ):@G+@4OY#-UD7""2]6
M47435$D9,5RN,GI8,N<V%#8'E%W40 EQ]N[$S7&#&Y5S79B!$HS2)KJXDAZ$
M6:9S'_N"=+8@?#8BQ%>7+C*YS9C/14%/HCTMF8 /W-1(P=%7E$2C=*"0/I03
M)IKP YR 6Q-9M[:<?CN$;7A?CLCY>XB+CXUD<$1>NY+</E\"C;%L0O08.WQJ
MVD@V"Z!$)5(P8U'\[']\K/\A;5!MXZ*O-=0&Z908+53#S":AB ;3%;KT1(RE
M9D^I!"P6[%;2HANY$S-7E.T^H'ZO5;P,"5)9O?%&I?F!N&-YM=ADMR9PN<OL
MU=9Y(2T!ZO="+CF50H1N1^3D[;$-&559=$E#G,?YX2X/.6DE*=N):%XS%'>)
M@LN/'1&]MH14?P"M:D]/"L>6W'PGU8!9N98L=76I#@5$V.5A6B\SZ1B"JG/N
MEW5)14*W+3VEW]Q;2!T0U6Y4:]J=I-SH*@FES7O*77AN&2B-Y&6XV62TFN[@
M2H$(T12^U0K]_N[KE,V M27N#4Z,.(_DO[EQH:?1BR+V<$7*#E,R(9>HJV@C
MR?EK6YJI#RP2RIV@1L[^)#<L2^Q8=T9OLLL (Z<F!SH-'6NJKPSG<-CQ%0O
M/JJ5!(374\,Y*\87.;W\6%/G"AT::X =+II$:-T]+[J,[!QWQHI#S0$6G3TT
MZ.-3'26M)4;=Z)F2*>+@C")F5:O,VU-WCS)EK=/5)?%;'''0-KBQT7CUS%S>
M]4EAATT=>$;+LV=%,%&A!93I=+>(LN@F'X"\&;4EQ93A&M6_"F5HJXKKUHL@
M(*J*?,WY^KWF@)J[9Z7+)%]LY)2E%A<NJ'>%(S53'A\IPD6N=K>RDYT\5^BI
M ).L5N.WJ%GWV_M2@B'O#-SIL6G5*3J, /8:4DLY8Q9Z@!U[JF.$N0:(UQ2Q
M\T"<2S_AZQ2,2R,5:&3RU!5>FLW%P2.Q3,/&]#V5KHLKCIRA_'3I( [<7=DP
M&B>Y<ND8X?:HEIO#? <AGLG@SVK&A4+Z6+7@L)Q"#08TZOEVMF!MUS%B5_BX
M_9ZOAMZF5DM,[4*-=U#W(4A$&;M;$?=3Q5'F$J@]>&502[W%$9:;DM7+JI!Q
MGE8*?9DB5,BI2<(XB>Y]P9FDMK?=8',%6:'XT\99 $GJ1Z&3EJ42RX]U)P!0
M3,-"SR;]WK?+TPZ2W6_W/&Z4Y>V0U,<'=R2J03C?<>-PJ5NI_T8VI64'UHC:
MN;B[V@4NS#B)#-CB)R_K#!2$Q@PDX904E2V;OC1V3!$YCFRI0O:Y_CAJN1MB
MMP8LD]3G!9LYG?'>&S<11R>*Q-IF]IS25ZU=-MS,PAW8B+O6+*1 [F7>YKSY
MW*F=PS 71\,P7EFHCI1D'ZAH>)*/3=F[FB7;E=<.B(49PYIDK82N]#*1A'#0
ME._Z%JG@PT6I(/>"+V0+Z1B1B3&RV;R60Z0^B+X'XX*'< J70Y!)YU5YR*IU
MU%8GR<F>S:![M^>) NH(R@9Q%D')I^CPR"<@Q<PF+J?,G'Y/FU RAP8<@)BQ
MD:R<=UQ=8"S>",=+G9BA<U<#]<KF5R:]R.-D)RU-KNU 9D0OYW3JHAD(#,V]
MK<TH^5=*]_12QI,:9]Y;SSY1''>B44#N'*3^5FF$8DK^113-[?IL#H_4FQF3
M^!FM^TZJLY^;;Y9::YX\N:GYYLF72\TW"?,-%FMA/^+]2%TN9@#PM-!#FQRI
MUPAXA#:O'6'\L-,;$Y^B*YMV?_*Y]>?/M]=W-;/*]KK?6V[B6!VBDI":9C$Y
MQ"L 7>R]96>-E!ENV)@OY]I/S#'$J0L>D^?YF$'M 4AT5KL 8H,W+BL9!9G#
M:@\MKZ8)6WD1R4'=D!6A5E\>'I&A[B&-U++1+>KB=.*X33CZA+?K+A'DCL1/
M7HMDPA!U6RT?O-OS\IL/I#KG41\^T WM,F'FKUWEYS,(,"M#MXU7\?AQ\+7!
M:]>4?OC_X%S?U=!J&"D/Z/K09'GC:]IV\B<2M@AIJ2!!;1IT>M,',5.!)T:5
MA^R1:%'-;'6&F[M!$B9\=.J)Q9S D8;1SSBD+)G&W3 KSJNU9BY":W\7E/5C
M\O7<9,RDA.ARRU(IC^]J6I&*H= FA*>::8[4*7ZD\NM_-&7UQ R\:=7;.#O&
MT\"2SN"100FQI?#?&OW(]'REW3-X[]Q9) WI16@9B$78?F]=/B2^%V6J^1T9
ME%/@N"YMAFE]*.P'GO>24V"=2&&*:NG&IF*^-OD2-J-YH-9N>^J40KBUHX]1
ME^JI3/M*NH$"LCCYH6]\=JXYJ>OR,+'+H 2(J4NJH\YGDN-@T$JW%^C5W:AH
M1F+6[$HI&4(0IZ":.O;02(*]X'DLDKUY>VG)(+%_6-;%U@*QE\W:/< T>K@&
MB**[6$PLWPRMY'*:761J4F"GEZG0F2EZXG(4LV=G\B:<-:0 ^*D 06VF-KX:
M@I"BY34+'#E+4\NHSBASM%PNVEN/*D[FKAMQ;.W7KH)TP-@VPW=7(XVLM/C-
M''6R=RL0=&^-MZ>U+N[W7NFY:/,E3R&^'2ATSM-'TNUIJ(RQ@ <Y*RQGP<G=
MY-3/TON!.LON?#A)#;>:AO'83,3M'C4%+\3KE.P:4\9)!@(&,O4+XT&. AN,
M08P\HK*BQ+7P1[IIG(Y?<; 3 9*\& _#QFX1&C?F@^-.,AYY8F>96"NR 8^B
MAGM7!K?C##B0SC#M9;:Y@X<YO>-""@R<)N)[**'?3D:3*T2M;\-:9U"/[1QA
M5C %P7VK-WUSE>D)6' [^/_>^KU>B,UD O^S ONF-JG#T!]-7H4XE^RZ3J*)
MXJ9(J5K^)I:ON7=DL\"!V&9B>+P2OV6P;6-R@F%#A;\E[2$6LPP3*?$-'12$
M"2=&8D=.N*PRKQ%U5?FV#*TD]Z8 2\0,N5DT[[MZ:4R<<1\)CEOT%DF,;[LA
M$@=]<I.K,(AN(R>?+7>OT>LEX*^$(F)X719W,I$V!0]$=FE/9;9GY9L\/:M)
M?@E-':K7 \BDJH2QNDGVSJ-+: "3F;].KVB=U[PX^9]W'+"R<Z7'1K8-0SA[
M_WN\?_$)OQ'T=NGQ)Y\SX7]N)OS)YTSXIR(QO\&"7/#[44W"<YV<":(<*M0@
M)2[9_M?O_FA>[<I&^:;WA]:/=NNX\K[2/?66W_3*F>JDWEM>*!HC3TJRA5<5
M4KLKM2/%G@*PEKQVB,8E:K,B[P']A/7S;]4?M]_F=IKF ?/R!Y2+R,>#R/*-
MS-X>DDTC[E&WM,3['G?YD3KK$-YDW'-;^$&C3WX/"CI*^J:3;+KY=T-!E[/T
M5GA:-10WX_]W++[^Q=6J]=[J[:+#QV#I"#8J)4^SL48WG>+#7HGX#W<*S+[?
M!]%@!]0_-:V'8#VCK/:?A[6[4ARKZY[!&JV>=;#IE9E+2 C.R5W:[243O62#
M&@/2-AC+!N5C%:KXHQNMR<<;D/:[48Y?OGE]V9'0D9[:;/'L)B!7_>3G)Z<O
M7IR_O3P_4Z>O\>^['\[/SY[)GSB@74[6\\NF-[5\#&^O9<P[TS,W!B1WADN2
M^?5_86$M*G\_WNX.=(E%_J+ G\']A; _W3\\V)<_57(;@-N*YVX\TS]$>]W/
M)O>V\&TR#U^V&O->:5]^3C_\&>F'+__0],.]Y0+6>6BW$*M]^DM/)_RGG^@O
M1/T?4$L#!!0    ( )*"NUH9$>=5$0L  'XA   6    =&TR-3$V,3,X9#%?
M97@Y.2TQ+FAT;=5:;4\;21+^;LG_H8Z3HJS.-B]9P@98=& @L.+MP%EI/YW:
M,VU/'S/=D^X>C/?7WU/=,_;@(PFK8Z5L%,5XIKNZ7IYZJKK"_MGH\N*@V]D_
M.SD\QB?QG_W1^>CBY&!_/7[B[7K]>O_H^O@WNAO]=G'R\]K$:+]+FQNEIY$J
MI*,K.:-;4PC=BP]Z=">MFJQA([;>-/N\?/1]D:NIWJ5$:B_M'KU4UAX5PDZ5
M[GM3[A*6+QZ,C?>F",_6#O:/#M[HL2OW]M>/8,?-B@8O/ZVMJU73S/]1!4X>
M,S56GCY\&&R^IC*-XUZJS?[YY4>ZNQW^O*8*,97_WMC8'/RGG*[1X<7HY[5A
M+H6]@V"Z,%.SUJB6239YEW9VRL<]FJG49[OT[MU/Y2/+O&V6);Q[EW!DMA;0
M\A4S?WQIA(/JM/&<U<&@I<HCF63:Y&:J('5H;&FL\,IH.M3:5#J1KML99D)/
M\=H;.C+"IF0F=*RL3+RQ[O^-RQ.%7Q%\*W(;H:^IZ.C3Q=UACZ[O<S'HT:68
MT]9.C[8VMK99>>KWZ=M^[G;>7@F7BL^[-+PXO_V!WK[)T\^5V5ML?6/#=S*6
M?":I>6V*4NAY_?*''@E-LI"LXI2P-966E,;?M'+>*I%38HHQ?N;8"IV2D]KQ
M6M]2K-OQF?#DJA+J>4IE(NS8:/5[4#4DPD%O?_W\@.V+'E5%:<V#)%/*:!!.
M8O%20Y<YR<E$)4KJ9-[#(S'.93"B<I)!E,U3:Z82"CD2-*EDLQ> 2V2WX\1$
M^CG-,H5]J14%3DA$GL_)RK1*6'U9*.=P+.+D38H0B!JW*05;^+2%KQS[RCT#
M8GK;<FUXW3B6,@&W/!C/ @W)QY(UA&>=^EW2Q)J")@KVXYV3#S E7<@,"ST)
M.%-IWG^H?6;T',=^5'AI"JE58L*Z"U/1D4!,I NR)BK/$8<D(RUGL#>Q4D $
M-!$)?,,@XFWA5(OCX<!"%F.)8V$7&Q.LZ'$ H(Z*2\PD!BU =2M"=4"GE<4&
MVR,@HPWB'AV+!Y72Y0"/<XD(BOJ0;N?I(=IX-5'!Y0MO1_?C^XQ-P0IRGE6>
M ,=6]F7.:N'$JL0_O ^N537W,#04^$;:@KX00U:PVT&P*P"ND-(S&+#/>9/<
M9R8'_MV 1HV.',:@Q%PRKEFRTE!XEDFVG>,4] RXDOCJ8H"AK#98"N?#>BO+
M7"1(,^T7<8:"G#:L+NAB\#U35HWO<Q(%/4@[IQ)$X2*P9S('0<A0AQ9 ;9")
M]\MHUYG!V0EP_*(*.I9YSOBYR0;'(,)AIN2$3AYE4@7@73,'P,>(SH+4!LMD
MPWF9P+*Q1/;DABD)1C0D5".ZM1$Q519H48YCWNW<:S/+93J5#?(; ,;\<T\8
M+K!@C+S"P3[(2D2I/,-(V'N)#4 B_ ?2DE%&Y% DH=$ZHM9%M!3B/O 9W"GR
MBMF-(9D2*!$PBEF7IBKN:#MQ0(?U<V:S1:)QE@6DXD@0G6](K)U%8QD3B?&^
MFDMU)E5EPIB=?BL_>L&\&9L@]#U2K@@2&<O,*@@:*[UT?1WY[QGBEW:P2J_L
MSX"MF;'W[(40^5AG$#)^HO2#=#ZD-9C:=#NP.)_WX6>@*E7.5F4(YA,DL:L*
MXWS#5JB54N+X,QF.Y-,0/\&(=BIE^ICQA^5>BO<D :8L"=5DK,Q"./!02(Y_
MWNVDDL, <S,TD]1>P@98U(M9**IUN74EZ F\]XP;DLIBN4<M"17#<3T(V1*R
M%?J,H)D3-;Q9^H+AS*3;N3P^HF&=)V> #]P&K2XNAO3VZO#N^/!?NX0E9]R(
MT-B:>VG[J02>;1 U 8.B:G%OD#XH9Y!,$P5R'P?Z@?W'R ,!@2/YR!^H^"A]
MT"XQ_0G*>1I7;7[XL -0.VIK\]&:J@RJ#.C&PE^F<IQ368Q#L#9M4F/<E/YE
MF<:7&VYA=$BA(V5Z=*Z3 1L"[\N<.QM>5%2Y5V5H1*HI"[-0 *'I=D(7\(M
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MXNLM+(PA@8==288(HC?IP1!OS?*KYWMTF)^'49"9A4G\LKZ=AKF!1;NC='!
MC'V<Q=$#]YIUVIU>7XT6_TW$%Y9=^OO&]OMWPTTDYZ>#V6PV"/][Q+DR@+;[
MZY^0I[SKX+N^UX!8V F3.'>FEAMV_R(4!KGGX2H%,VYEO&>[77KE4RZ%AX-F
M>,M3*FE?4?0I3U_.;^/U(M#G(J]?\91_;-*/F]O][9VM_D^;VUNO)GF/GDF'
MPM5N^B=?>)2=LFE-6KS^+/W5D^(%S=O6'N[!-=8N<(/X?GJY/[.Q:ARSSK\_
M$7^A@G_OXK]02P$"% ,4    " "2@KM:J1JIZ"H#  #E"P  $0
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M2P$"% ,4    " "2@KM:C$V2Q7I'  "S> $ %@              @ $9/
M=&TR-3$V,3,X9#%?97@Q,"TQ+FAT;5!+ 0(4 Q0    ( )*"NUHZ/5A;-TH
M "F% 0 6              "  <>#  !T;3(U,38Q,SAD,5]E>#$P+3(N:'1M
M4$L! A0#%     @ DH*[6N-SYBIF%@  UV4  !8              ( !,LX
M '1M,C4Q-C$S.&0Q7V5X,3 M,RYH=&U02P$"% ,4    " "2@KM:VL^22F$6
M   H:@  %@              @ ',Y   =&TR-3$V,3,X9#%?97@Q,"TT+FAT
M;5!+ 0(4 Q0    ( )*"NUH9$>=5$0L  'XA   6              "  6'[
M  !T;3(U,38Q,SAD,5]E>#DY+3$N:'1M4$L%!@     )  D 60(  *8& 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2516138d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clir-20250522.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434524</identifier>
        </entity>
        <period>
            <startDate>2025-05-22</startDate>
            <endDate>2025-05-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-22" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-22" id="Fact000004">0001434524</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-22" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-22" id="Fact000010">2025-05-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-22" id="Fact000011">CLEARSIGN TECHNOLOGIES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-22" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-22" id="Fact000013">001-35521</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-22" id="Fact000014">26-2056298</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-22" id="Fact000015">8023 E. 63rd Place, Suite 101</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-22" id="Fact000016">Tulsa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-22" id="Fact000017">OK</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-22" id="Fact000018">74133</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-22" id="Fact000019">918</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-22" id="Fact000020">236-6461</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-22" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-22" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-22" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-22" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-22" id="Fact000025">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-22" id="Fact000026">CLIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-22" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-22" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
